Dermatitis disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: DRM006 MIFTS: 62	Dermatitis Categories: Skin diseases	Data Licensing For inquiries, contact: [email protected]
Genes Variations Tissues Related diseases Publications Symptoms & Phenotypes Drugs Collapse all tables

Sources

Aliases & Classifications for Dermatitis

MalaCards integrated aliases for Dermatitis:

Name: Dermatitis ¹¹ ⁵³ ⁵ ⁴³ ¹⁴ ⁷¹ ⁷⁵

Eczema ¹¹ ⁷⁵ ²⁸ ⁵³ ⁵ ⁴¹ ⁶³ ⁷¹

Skin Inflammation ¹¹ ¹⁴

Inflammatory Dermatosis ⁷¹

Classifications:

MalaCards categories:
Anatomical: Skin diseases

See all MalaCards categories (disease lists)

ICD10: ³¹

Diseases of the skin and subcutaneous tissue

Dermatitis and eczema

Dermatitis due to substances taken internally

Dermatitis due to ingested food

Dermatitis due to other substances taken internally

Dermatitis due to unspecified substance taken internally

Other dermatitis

Dermatitis, unspecified

Other specified dermatitis

External Ids:

Disease Ontology ¹¹ DOID:2723

MeSH ⁴³ D003872

NCIt ⁴⁹ C2983

SNOMED-CT ⁶⁸ 238538009

ICD10 ³¹ L27 L27.2 L27.8 more

UMLS ⁷¹ C0011603 C0013595 C3875321

Sources

Summaries for Dermatitis

MedlinePlus: ⁴¹ Eczema is a term for several different types of skin swelling. Eczema is also called dermatitis. Most types cause dry, itchy skin and rashes on the face, inside the elbows and behind the knees, and on the hands and feet. Scratching the skin can cause it to turn red, and to swell and itch even more. Eczema is not contagious. The cause of eczema is unknown. It is likely caused by both genetic and environmental factors. Eczema may get better or worse over time, but it is often a long-lasting disease. People who have it may also develop hay fever and asthma. The most common type of eczema is atopic dermatitis. It is most common in babies and children, but adults can have it too. As children who have atopic dermatitis grow older, this problem may get better or go away. But sometimes the skin may stay dry and get irritated easily. Treatments may include medicines, skin creams, light therapy, and good skin care. You can prevent some types of eczema by avoiding: Things that irritate your skin, such as certain soaps, fabrics, and lotions Stress Things you are allergic to, such as food, pollen, and animals NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases

MalaCards based summary: Dermatitis, also known as eczema, is related to irritant dermatitis and dermatitis herpetiformis, and has symptoms including pruritus and exanthema. An important gene associated with Dermatitis is FLG (Filaggrin), and among its related pathways/superpathways are Innate Immune System and MIF Mediated Glucocorticoid Regulation. The drugs Salicylic acid and Ciclopirox have been mentioned in the context of this disorder. Affiliated tissues include skin, breast and t cells, and related phenotypes are immune system and hematopoietic system

PubMed Health : ⁶³ Eczema: Eczema is a common, chronic, non-infectious skin condition. The main symptom of this inflammatory disease is a very itchy rash. It often affects children. In many cases eczema gets better as the years go by, and it may go away for a while or disappear altogether. Acute flare-ups can really affect quality of life. The itching can be especially bad, making it difficult to concentrate and sleep well. Some people are embarrassed if their rash is visible to others. By taking good care of your skin, using medication and avoiding irritants and other things that can trigger the eczema, it is usually possible to relieve the symptoms at least enough to live a fairly normal life. Eczema is sometimes also called "atopic eczema" or "atopic dermatitis."

Disease Ontology: ¹¹ A skin disease characterized by itchy, erythematous, vesicular, weeping and crusting patches of skin.

Wikipedia: ⁷⁵ Dermatitis is inflammation of the skin, typically characterized by itchiness, redness and a rash. In... more...

Sources

Related Diseases for Dermatitis

Diseases related to Dermatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 2086, show less)

#	Related Disease	Score	Top Affiliating Genes
1	irritant dermatitis	33.2	TSLP IL4 IL31 IL13 FLG CCL27
2	dermatitis herpetiformis	33.2	IL5 IL4 IL31 CCL11
3	allergic contact dermatitis	33.2	TSLP SPINK5 IL5 IL4 IL31RA IL31
4	contact dermatitis	33.2	TSLP SPINK5 IL5 IL4 IL31RA IL31
5	dermatitis, atopic	33.2	TSLP SPINK5 NOD2 IL5 IL4 IL31RA
6	seborrheic infantile dermatitis	33.0	ZNF750 FLG
7	cercarial dermatitis	33.0	IL5 IL4
8	eczema herpeticum	32.9	TSLP SPINK5 IL4 IL31 IL13 IGHE
9	occupational dermatitis	32.8	IL31 FLG
10	seborrheic dermatitis	32.7	ZNF750 SPINK5 FLG DSG1 BTD
11	nickel allergic contact dermatitis	32.7	IL5 IL13
12	chromium allergic contact dermatitis	32.6	IL5 IL4 IL13
13	blau syndrome	32.6	NOD2 NLRP3 IL4
14	allergic rhinitis	32.4	IL5 IL4 IL13 IGHE CCL17 CCL11
15	bullous pemphigoid	32.3	IL5 IL4 IGHE DSG1 CCL17 CCL11
16	celiac disease 1	32.3	TSLP NOD2 IL5 IL4 IL13
17	netherton syndrome	32.3	SPINK5 IGHE FLG DSG1
18	allergic asthma	32.2	TSLP IL5 IL4 IL13 IGHE CCL17
19	ige responsiveness, atopic	32.2	SPINK5 IL5 IL4 IL13 IGHE
20	chronic rhinitis	32.1	IL5 IL4 IL13
21	metal allergy	32.1	IL5 IL4 IL13 FLG
22	milk allergy	32.1	TSLP IL5 IL4 IL13 IGHE
23	egg allergy	32.0	TSLP IL5 IL4 IL13 IGHE FLG
24	hyper ige syndrome	32.0	SPINK5 IL4 IGHE CCL11
25	rhinitis	32.0	TSLP IL5 IL4 IL13 IGHE FLG
26	food allergy	32.0	TSLP IL5 IL4 IL13 IGHE FLG
27	neurodermatitis	32.0	TSLP IL4 IL31RA IL31 IL13 FLG
28	pollen allergy	32.0	IL5 IL4 IL13
29	skin disease	32.0	TSLP SPINK5 NOD2 NLRP3 IL5 IL4
30	allergic disease	32.0	TSLP IL5 IL4 IL13 IGHE FLG
31	filariasis	31.9	IL5 IL4 IL13 IGHE
32	onchocerciasis	31.9	IL5 IL4 IL13 IGHE DSG1 CCL11
33	psoriasis	31.9	SPINK5 NOD2 IL5 IL4 IL31 IL13
34	pyoderma	31.9	NOD2 NLRP3 DSG1
35	asthma	31.8	TSLP SPINK5 NOD2 NLRP3 IL5 IL4
36	urticaria	31.7	TSLP NLRP3 IL5 IL4 IL31 IL13
37	hypereosinophilic syndrome	31.7	IL5 IL4 IL13 IGHE CCL17 CCL11
38	conjunctivitis	31.7	NLRP3 IL5 IL4 IL13 IGHE CCL11
39	erythema multiforme	31.6	IL5 IL4 IL13 CCL17
40	pemphigoid	31.5	IL5 IL4 IL31 IL13 DSG1 CCL11
41	fungal infectious disease	31.5	IL5 IL4 IL13
42	folliculitis	31.5	IL5 IL4 CCL11
43	skin atrophy	31.4	IL4 IL31 FLG
44	mycosis fungoides	31.4	IL5 IL4 CCL22 CCL17
45	lichen planus	31.4	IL4 FLG DSG1
46	ichthyosis vulgaris	31.4	TSLP SPINK5 FLG DSG1
47	alopecia areata	31.4	IL4 IL13 FLG
48	scabies	31.3	IL5 IL4 IL31 IL13 FLG
49	schistosomiasis	31.3	IL5 IL4 IL13 IGHE
50	primary cutaneous t-cell non-hodgkin lymphoma	31.3	IL5 IL4 CCL17
51	allergic conjunctivitis	31.3	TSLP IL5 IL4 IL13 IGHE CCL11
52	chronic urticaria	31.3	NLRP3 IL5 IL31 IGHE
53	proteasome-associated autoinflammatory syndrome 1	31.2	NLRP3 IL5 IL4 IL13 IGHE CCL11
54	respiratory allergy	31.2	TSLP IL5 IL4 IL13 FLG CCL17
55	keratoconjunctivitis	31.2	IL5 IL4 IL13 CCL11
56	nasopharyngitis	31.2	IL5 IL31 IL13
57	common cold	31.2	TSLP IL5 IL4 IL13 CCL11
58	chronic spontaneous urticaria	31.1	TSLP IL5 IL4 IL31 IL13
59	bronchitis	31.0	IL5 IL4 IL13 IGHE CCL11
60	leishmaniasis	31.0	IL5 IL4 IL13
61	eosinophilic gastroenteritis	31.0	IL5 IL4 IL13 IGHE CCL11
62	peanut allergy	31.0	TSLP IL5 IL4 IL13 IGHE FLG
63	sezary's disease	31.0	IL5 IL4 IL31 CCL27 CCL17
64	respiratory failure	30.9	NLRP3 IL5 IL4 IL13 IGHE CMA1
65	occupational asthma	30.9	TSLP IL5 IL4 IL13 CCL11
66	ulcerative colitis	30.9	NOD2 IL5 IL4 IL13
67	mite infestation	30.9	TSLP IL5 IL4 IL31 IL13 FLG
68	drug allergy	30.9	IL5 IL4 IL13 IGHE
69	leprosy 3	30.9	NOD2 IL5 IL4 IL13
70	esophagitis	30.9	TSLP IL5 IL4 IL13 FLG DSG1
71	childhood-onset asthma	30.9	TSLP IL5 IL4 IL13 IGHE CCL17
72	candidiasis	30.9	NLRP3 IL5 IL4
73	aspergillosis	30.9	NOD2 IL5 IL4 CCL17
74	ascaris lumbricoides infection	30.8	IL5 IL4 IL13
75	blepharoconjunctivitis	30.8	IL4 IL13
76	colitis	30.8	NOD2 IL5 IL4 IL13
77	crohn's disease	30.8	NOD2 NLRP3 IL5 IL4 IL13
78	diphtheria	30.8	IL5 IL4 IL13
79	esophagitis, eosinophilic, 1	30.8	TSLP SPINK5 IL5 IL4 IL13 FLG
80	hidradenitis	30.8	NOD2 NLRP3 DSG1
81	tetanus	30.7	IL5 IL4 IL13
82	osteomyelitis	30.7	NOD2 NLRP3 IL4
83	severe combined immunodeficiency	30.7	IL5 IL4 IL13 IGHE
84	parasitic helminthiasis infectious disease	30.7	TSLP IL5 IL4 IL13 CCL11
85	gastroenteritis	30.7	IL5 IL4 CCL11
86	otitis media	30.6	SPINK5 NLRP3 IL5 IL4 IL13 IGHE
87	cow milk allergy	30.6	IL5 IL4 IL13
88	latex allergy	30.6	IL13 IGHE
89	uveitis	30.6	NOD2 IL4 CCL11
90	churg-strauss syndrome	30.6	IL5 CCL17 CCL11
91	filarial elephantiasis	30.5	IL5 IL4 IL13
92	cutaneous leishmaniasis	30.5	IL5 IL4 IL13 IGHE
93	toxoplasmosis	30.5	NOD2 IL5 IL4
94	strongyloidiasis	30.5	IL5 IL4 IL13 IGHE CCL11
95	bronchiolitis	30.5	IL5 IL4 IL13 CCL11
96	cystic fibrosis	30.5	NOD2 NLRP3 IL5 IL4 IL13 CCL17
97	intrinsic asthma	30.5	TSLP IL5 IL4 IL13 IGHE CCL11
98	vernal keratoconjunctivitis	30.5	IL4 IL13 CCL11
99	meningitis	30.5	NLRP3 IL5 IL4 IL13
100	interstitial lung disease	30.5	IL4 IL13 CCL17 CCL11
101	vasomotor rhinitis	30.5	IL5 IL4 IL13 CMA1 CCL11
102	omenn syndrome	30.4	SPINK5 IL5 IL4 IGHE
103	enterobiasis	30.4	IL5 IL4
104	behcet syndrome	30.4	NOD2 NLRP3 IL5 IL4 IL13
105	norwegian scabies	30.4	IL5 IL13 CCL27
106	exercise-induced bronchoconstriction	30.4	TSLP IL5 IL4 IL13 IGHE
107	pneumonia	30.4	IL5 IL4 IL13 CCL22 CCL11
108	acute asthma	30.3	TSLP IL5 IL4 IL13 CCL11
109	peeling skin syndrome	30.3	SPINK5 FLG DSG1
110	kimura disease	30.3	IL5 IL4 IGHE
111	elephantiasis	30.3	IL5 IL4 IL13
112	respiratory syncytial virus infectious disease	30.2	IL5 IL13
113	peritonitis	30.2	NOD2 NLRP3 CMA1
114	conjunctival disease	30.2	TSLP NLRP3 IL5 IL4 IL13 CCL11
115	chronic asthma	30.2	TSLP IL5 IL4 IL13 CCL17 CCL11
116	chronic conjunctivitis	30.1	TSLP IL5 IL4 IL13 IGHE CMA1
117	toxocariasis	30.0	IL5 IL4 IL13 IGHE
118	mucocutaneous leishmaniasis	30.0	IL5 IL4 IL13
119	loiasis	30.0	IL5 IL4 IL13 CCL11
120	igg4-related disease	30.0	IL5 IL4 IL13
121	intestinal schistosomiasis	30.0	IL5 IL4 IL13
122	t2-high asthma	30.0	TSLP IL5 IL4 IL13
123	mansonelliasis	30.0	CCL22 CCL17
124	parasitic ectoparasitic infectious disease	30.0	IL5 IL4 IL31 IL13 FLG
125	allergic bronchopulmonary aspergillosis	30.0	IL5 IL4 IL13 IGHE CCL17
126	radiculopathy	30.0	IL5 IL13 CCL11
127	interstitial lung disease 2	30.0	TSLP NLRP3 IL5 IL4 IL13 CCL22
128	eosinophilic pneumonia	30.0	IL5 IL4 IL13 CCL22 CCL17 CCL11
129	vernal conjunctivitis	30.0	IL4 CMA1 CCL11
130	visceral leishmaniasis	29.9	IL5 IL4 IL13
131	disseminated eosinophilic collagen disease	29.9	IL5 CCL17
132	esophageal candidiasis	29.9	IL5 IL13
133	brucellosis	29.8	NLRP3 IL4 IL13
134	familial mediterranean fever	29.8	NOD2 NLRP3 IL4
135	silicosis	29.8	NLRP3 IL4 DSG1
136	dacryoadenitis	29.5	IL4 IL13
137	dermatitis, atopic, 2	11.6
138	chronic actinic dermatitis	11.5
139	immunodeficiency 11b with atopic dermatitis	11.5
140	toxicodendron dermatitis	11.4
141	microcephaly, congenital cataract, and psoriasiform dermatitis	11.4
142	photoallergic dermatitis	11.4
143	dermatitis, atopic, 3	11.4
144	phototoxic dermatitis	11.4
145	erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper-ige	11.4
146	dermatitis, atopic, 5	11.4
147	dermatitis, atopic, 4	11.4
148	exfoliative dermatitis	11.4
149	dermatitis, atopic, 6	11.4
150	dermatitis, atopic, 8	11.4
151	dermatitis, atopic, 7	11.4
152	seborrhea-like dermatitis with psoriasiform elements	11.4
153	interstitial granulomatous dermatitis with arthritis	11.4
154	dermatitis, atopic, 9	11.4
155	agammaglobulinemia, microcephaly, and severe dermatitis	11.3
156	infective dermatitis associated with htlv-1	11.3
157	1,4-phenylenediamine allergic contact dermatitis	11.3
158	1-chloro-2,4-dinitrobenzene allergic contact dermatitis	11.3
159	granulomatous dermatitis	11.3
160	benzo[d]isothiazol-3-one allergic contact dermatitis	11.2
161	autoinflammation, immune dysregulation, and eosinophilia	11.2
162	palladium allergic contact dermatitis	11.2
163	4-tert-butylphenol allergic contact dermatitis	11.2
164	neurotic excoriation	11.2
165	spongiotic dermatitis	11.2
166	contagious pustular dermatitis	11.2
167	cobalt allergic contact dermatitis	11.2
168	diphenylmethane-4,4'-diisocyanate allergic contact dermatitis	11.2
169	benzoic acid allergic contact dermatitis	11.2
170	ketoprofen photoallergic dermatitis	11.2
171	carvone allergic contact dermatitis	11.2
172	neomycin sulfate allergic contact dermatitis	11.2
173	parthenolide allergic contact dermatitis	11.2
174	formaldehyde allergic contact dermatitis	11.2
175	2,4-dinitrophenyl allergic contact dermatitis	11.2
176	juvenile dermatitis herpetiformis	11.2
177	acrodermatitis enteropathica, zinc-deficiency type	11.2
178	growth retardation, small and puffy hands and feet, and eczema	11.2
179	acneiform dermatitis	11.1
180	immunodysregulation, polyendocrinopathy, and enteropathy, x-linked	11.1
181	progestogen hypersensitivity	11.1
182	potassium dichromate allergic contact dermatitis	11.1
183	n,n'-diphenylthiourea allergic contact dermatitis	11.1
184	n,n'-diethylthiourea allergic contact dermatitis	11.1
185	dermatophytosis	11.1
186	holocarboxylase synthetase deficiency	11.1
187	subcorneal pustular dermatosis	11.1
188	thrombocytopenia 1	11.1
189	noonan syndrome-like disorder with loose anagen hair	11.1
190	photoparoxysmal response 1	11.0
191	dermatitis herpetiformis, familial	11.0
192	autoimmune disease, multisystem, infantile-onset, 1	11.0
193	immunodeficiency 63 with lymphoproliferation and autoimmunity	11.0
194	acrodermatitis	11.0
195	autoinflammatory syndrome, familial, x-linked, behcet-like 2	11.0
196	allergic contact dermatitis of eyelid	11.0
197	garret tripp syndrome	11.0
198	pellagra	11.0
199	wiskott-aldrich syndrome 2	11.0
200	myeloproliferative/lymphoproliferative neoplasms, familial	11.0
201	growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant	11.0
202	autoinflammatory syndrome, familial, with or without immunodeficiency	11.0
203	immunodeficiency 85 and autoimmunity	11.0
204	asthma-related traits 4	11.0
205	psoriasis 2	10.9
206	psoriasis 11	10.9
207	psoriasis 1	10.9
208	psoriasis 7	10.9
209	psoriasis 13	10.9
210	porphyria cutanea tarda	10.9
211	asthma-related traits 2	10.9
212	immunodeficiency 23	10.9
213	yao syndrome	10.9
214	immunodeficiency 58	10.9
215	prurigo nodularis	10.9
216	systemic lupus erythematosus	10.9
217	ameloonychohypohidrotic syndrome	10.9
218	asthma-related traits 1	10.9
219	zinc deficiency, transient neonatal	10.9
220	asthma-related traits 5	10.9
221	asthma-related traits 7	10.9
222	proteasome-associated autoinflammatory syndrome 3	10.9
223	proteasome-associated autoinflammatory syndrome 2	10.9
224	hyper-ige recurrent infection syndrome 3, autosomal recessive	10.9
225	t-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant	10.9
226	hyper-ige recurrent infection syndrome 5, autosomal recessive	10.9
227	stuve-wiedemann syndrome 2	10.9
228	ritter's disease	10.9
229	chromoblastomycosis	10.9
230	leiner disease	10.9
231	tropical spastic paraparesis	10.9
232	exanthem	10.9
233	agammaglobulinemia, x-linked	10.9
234	fixed drug eruption	10.9
235	pigmented purpuric eruption	10.9
236	deafness, neural, with atypical atopic dermatitis	10.9
237	atopic keratoconjunctivitis	10.8
238	pityriasis rosea	10.8
239	biotinidase deficiency	10.8
240	drug reaction with eosinophilia and systemic symptoms	10.8
241	eczematous dermatitis of eyelid	10.8
242	growth hormone insensitivity syndrome with immune dysregulation 1, autosomal recessive	10.8
243	hyperphenylalaninemia, bh4-deficient, a	10.8
244	immunodeficiency 50	10.8
245	chromosome 2q37 deletion syndrome	10.8
246	nicolaides-baraitser syndrome	10.8
247	chromosome 15q11-q13 duplication syndrome	10.8
248	immunodeficiency 31c	10.8
249	loeys-dietz syndrome 4	10.8
250	immunodeficiency 7	10.8
251	loeys-dietz syndrome 5	10.8
252	immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia	10.8
253	immunodeficiency 55	10.8
254	trueb burg bottani syndrome	10.8
255	hereditary thrombocytopenia with normal platelets	10.8
256	intellectual disability-seizures-macrocephaly-obesity syndrome	10.8
257	congenital progressive bone marrow failure-b-cell immunodeficiency-skeletal dysplasia syndrome	10.8
258	actinic prurigo	10.8
259	primary cutaneous amyloidosis	10.8
260	ackerman syndrome	10.8
261	balanitis	10.8
262	fish allergy	10.8
263	balanoposthitis	10.8
264	bullous skin disease	10.8
265	erosive pustular dermatosis of the scalp	10.8
266	macular amyloidosis	10.8
267	13q12.3 microdeletion syndrome	10.8
268	deep dermatophytosis	10.8
269	kindler syndrome	10.8
270	nail disorder, nonsyndromic congenital, 4	10.8
271	vexas syndrome	10.8
272	neurodevelopmental disorder with epilepsy and hemochromatosis	10.8
273	mental retardation, obesity, mandibular prognathism, and eye and skin anomalies	10.8
274	immunodeficiency 104	10.8
275	asthma-related traits 3	10.8
276	asthma-related traits 6	10.8
277	immunodeficiency, common variable, 8, with autoimmunity	10.8
278	immunodeficiency 12	10.8
279	autoinflammation, panniculitis, and dermatosis syndrome	10.8
280	immunodeficiency 82 with systemic inflammation	10.8
281	immunodeficiency 105	10.8
282	large congenital melanocytic nevus	10.8
283	mercury poisoning	10.8
284	linear atrophoderma of moulin	10.8
285	alopecia	10.7
286	rosacea	10.6
287	acne	10.6
288	pemphigus	10.6
289	cytokine deficiency	10.6
290	autoimmune disease	10.6
291	ichthyosis	10.5
292	thunderstorm triggered asthma	10.5	IL5 IL4 IL13
293	cough variant asthma	10.5	IL5 IL4 IL13
294	mikulicz disease	10.5	IL5 IL4 IL13
295	penicillin allergy	10.5	IL4 IL13 IGHE
296	nut allergy	10.5	IL5 IL4 IL13 IGHE FLG
297	urinary schistosomiasis	10.5	IL5 IL4 IL13 IGHE
298	angiostrongyliasis	10.5	IL5 IL13 CCL11
299	papillary conjunctivitis	10.5	IL5 IL4 IL13 CCL11
300	persistent severe asthma	10.5	TSLP IL5 IL4 IL13
301	aztreonam allergy	10.5	IL5 IL13
302	paragonimiasis	10.5	IL5 IL13 IGHE CCL17
303	eosinophilic meningitis	10.5	IL5 IL4 IL13 CCL11
304	taeniasis	10.5	IL5 IL4 IL13
305	cysticercosis	10.5	IL5 IL4 IGHE
306	near-fatal asthma	10.5	TSLP IL5 IL4 IL13
307	t2-low asthma	10.5	TSLP IL5 IL4 IL13
308	contact blepharoconjunctivitis	10.5	IL5 CCL11
309	giant papillary conjunctivitis	10.5	IL5 IL4 IL13 CCL11
310	rickets	10.5
311	chronic eosinophilic pneumonia	10.5	IL5 IL13 CCL11
312	viral infectious disease	10.5
313	eosinophilic gastritis	10.5	TSLP IL5 IL13 CCL11
314	cefaclor allergy	10.5	IL5 IL13
315	status asthmaticus	10.5	IL5 IL13 CCL11
316	adult syndrome	10.5
317	trichinosis	10.5	TSLP IL5 IL4 IL13 CCL11
318	intermittent asthma	10.5	TSLP IL5 IL4 IL13 CCL11
319	vitiligo-associated multiple autoimmune disease susceptibility 6	10.5
320	vitiligo-associated multiple autoimmune disease susceptibility 1	10.5
321	environmental induced asthma	10.5	TSLP IL5 IL4 IL13 CCL11
322	pulmonary eosinophilia	10.5	IL5 IL4 IL13 CCL17 CCL11
323	opportunistic mycosis	10.5	IL5 IL4 IL13
324	paranasal sinus disease	10.5	TSLP IL5 IL4 IL13 CCL11
325	fanconi anemia, complementation group e	10.5
326	leukocyte disease	10.5	IL5 IL4 IL13 CCL11
327	severe combined immunodeficiency, x-linked	10.5	TSLP IL4 IL13
328	legume allergy	10.5	TSLP SPINK5 IL5 IL4 IL13 FLG
329	fruit allergy	10.5	TSLP SPINK5 IL5 IL4 IL13 FLG
330	multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	10.5
331	loeffler syndrome	10.5	IL5 IL13
332	upper respiratory tract disease	10.5	TSLP IL5 IL4 IL13
333	vasculitis	10.5
334	pompholyx	10.4
335	commensal bacterial infectious disease	10.4	IL5 IL4 IL13 DSG1
336	aspirin-induced respiratory disease	10.4	IL5 IL13
337	bronchial disease	10.4	TSLP IL5 IL4 IL13 FLG CCL17
338	autoimmune disease of skin and connective tissue	10.4	IL5 IL4 IL13 FLG DSG1
339	parasitic protozoa infectious disease	10.4	IL5 IL4 IL13
340	herpes simplex	10.4
341	aggressive periodontitis	10.4	NOD2 IL4 IL13
342	autoimmune disease of musculoskeletal system	10.4	IL5 IL4 IL13 DSG1
343	abacavir allergy	10.4	CCL17 CCL11
344	immune deficiency disease	10.4
345	cataract	10.4
346	adenoid hypertrophy	10.4	IL5 IL4
347	nose disease	10.4	TSLP IL5 IL4 IL31 IL13 FLG
348	nasal cavity disease	10.4	TSLP IL5 IL4 IL31 IL13 FLG
349	skin carcinoma	10.4
350	vulvar syringoma	10.4	FAF2 CMA1
351	cellulitis	10.4
352	herpes zoster	10.4
353	chronic meningitis	10.4	NLRP3 IL5 IL13 CCL11
354	lupus erythematosus	10.4
355	head and neck cancer	10.4
356	impetigo	10.4
357	refractory plasma cell neoplasm	10.4	CCL22 CCL17
358	integumentary system disease	10.4	TSLP IL5 IL4 IL31 IL13 FLG
359	ehlers-danlos syndrome, arthrochalasia type, 1	10.4
360	autoimmune disease of gastrointestinal tract	10.4	NOD2 NLRP3 IL5 IL4 IL13
361	primary bacterial infectious disease	10.4	NOD2 NLRP3 IL5 IL4 IL13
362	diarrhea	10.4
363	purpura	10.4
364	attention deficit-hyperactivity disorder	10.4
365	decubitus ulcer	10.4
366	salmonellosis	10.4	NOD2 NLRP3 IL4
367	retinal detachment	10.3
368	autoimmune disease of central nervous system	10.3	IL5 IL4 IL13
369	angioedema	10.3
370	nutritional deficiency disease	10.3
371	lymphoma	10.3
372	oculodentodigital dysplasia	10.3
373	ceroid lipofuscinosis, neuronal, 5	10.3
374	keratosis	10.3
375	dermatomyositis	10.3
376	48,xyyy	10.3
377	cheilitis	10.3
378	phenytoin allergy	10.3	CMA1 CCL11
379	sarcoidosis 1	10.3
380	sarcoidosis 2	10.3
381	pemphigus vulgaris, familial	10.3
382	severe cutaneous adverse reaction	10.3
383	human t-cell leukemia virus type 1	10.3
384	overgrowth syndrome	10.3
385	molluscum contagiosum	10.3
386	telangiectasis	10.3
387	sodoku disease	10.3	CCL22 CCL11
388	leukocyte adhesion deficiency, type i	10.3
389	gastrointestinal system disease	10.3
390	pityriasis versicolor	10.3
391	stomatitis	10.3
392	acquired immunodeficiency syndrome	10.3
393	anxiety	10.3
394	basal cell carcinoma	10.3
395	chickenpox	10.3
396	spondyloarthropathy 1	10.3
397	deficiency anemia	10.3
398	adult t-cell leukemia/lymphoma	10.3
399	toxic shock syndrome	10.3
400	primary agammaglobulinemia	10.3
401	systemic lupus erythematosus 1	10.3
402	vaccinia	10.3
403	granuloma annulare	10.3
404	congenital hemidysplasia with ichthyosiform erythroderma and limb defects	10.3
405	basal cell carcinoma 1	10.3
406	children's interstitial lung disease	10.3
407	inflammatory bowel disease 1	10.2
408	covid-19	10.2
409	spinal cord disease	10.2
410	pik3ca-related overgrowth spectrum	10.2
411	pik3ca-related overgrowth syndrome	10.2
412	personality disorder	10.2
413	pyoderma gangrenosum	10.2
414	hereditary spastic paraplegia	10.2
415	blepharitis	10.2
416	spastic paraparesis	10.2
417	burkitt lymphoma	10.2
418	keratitis, hereditary	10.2
419	hypoascorbemia	10.2
420	rhabdomyosarcoma 2	10.2
421	ataxia with vitamin e deficiency	10.2
422	endocarditis	10.2
423	glomerulonephritis	10.2
424	gastritis	10.2
425	t-cell acute lymphoblastic leukemia	10.2
426	hypersensitivity vasculitis	10.2
427	alveolar echinococcosis	10.2	IL5 IL4
428	psoriatic arthritis	10.2
429	graft-versus-host disease	10.2
430	infective endocarditis	10.2
431	keratoconus	10.2
432	venous insufficiency	10.2
433	keratomalacia	10.2
434	panniculitis	10.2
435	gastric antral vascular ectasia	10.2
436	leukemia, t-cell, chronic	10.2
437	oto-palatal-digital syndrome	10.2
438	type 1 diabetes mellitus	10.2
439	lymphoma, hodgkin, classic	10.2
440	mucositis	10.2
441	hypothyroidism	10.2
442	x-linked intellectual disability-macrocephaly-macroorchidism syndrome	10.2
443	tatton-brown-rahman syndrome	10.2
444	paronychia	10.2
445	lymphadenitis	10.2
446	agammaglobulinemia	10.2
447	systemic scleroderma	10.2
448	dermatographia	10.2
449	dilution, pigmentary	10.2
450	melanoma	10.2
451	sleep disorder	10.2
452	annular erythema	10.2
453	sjogren syndrome	10.2
454	hemophilia a	10.2
455	otitis externa	10.2
456	47 xxx syndrome	10.2
457	49, xxxxy syndrome	10.2
458	fetal anticonvulsant syndrome	10.2
459	discoid lupus erythematosus	10.2
460	dermographism, familial	10.2
461	trichohepatoenteric syndrome 1	10.2
462	major depressive disorder	10.2
463	glass syndrome	10.2
464	alcohol use disorder	10.2
465	squamous cell carcinoma	10.2
466	epidermolysis bullosa	10.2
467	connective tissue disease	10.2
468	down syndrome	10.2
469	bacteremia 2	10.2
470	inflammatory bowel disease	10.2
471	hidradenitis suppurativa	10.2
472	rheumatoid arthritis	10.1
473	progressive non-infectious anterior vertebral fusion	10.1
474	cutaneous lupus erythematosus	10.1
475	chronic venous insufficiency	10.1
476	urinary tract infection	10.1
477	severe acute respiratory syndrome	10.1
478	syphilis	10.1
479	localized scleroderma	10.1
480	amyloidosis	10.1
481	alopecia universalis congenita	10.1
482	graves disease 1	10.1
483	lymphoproliferative syndrome	10.1
484	smallpox	10.1
485	anterior cutaneous nerve entrapment syndrome	10.1
486	alcohol dependence	10.1
487	immunoglobulin e concentration, serum	10.1
488	squamous cell carcinoma, head and neck	10.1
489	myelodysplastic syndrome	10.1
490	rapidly involuting congenital hemangioma	10.1
491	tinea pedis	10.1
492	cone-rod dystrophy 2	10.1
493	lichen sclerosus et atrophicus	10.1
494	pernicious anemia	10.1
495	neurodegeneration with brain iron accumulation 2a	10.1
496	helix syndrome	10.1
497	pemphigus foliaceus	10.1
498	sarcoma	10.1
499	cicatricial pemphigoid	10.1
500	pemphigoid gestationis	10.1
501	thymoma	10.1
502	palmoplantar keratosis	10.1
503	hypokalemia	10.1
504	thyroiditis	10.1
505	pustular psoriasis	10.1
506	paresthesia	10.1
507	myositis	10.1
508	wiskott-aldrich syndrome	10.1
509	human immunodeficiency virus type 1	10.1
510	leptin deficiency or dysfunction	10.1
511	autism spectrum disorder	10.1
512	histiocytosis	10.1
513	parapsoriasis	10.1
514	parkinson disease, late-onset	10.1
515	body mass index quantitative trait locus 1	10.1
516	mastitis	10.1
517	anhidrosis	10.1
518	erysipelas	10.1
519	vascular disease	10.1
520	lymphopenia	10.1
521	arthritis	10.1
522	measles	10.1
523	neuropathy	10.1
524	bowel dysfunction	10.1
525	renal cell carcinoma, nonpapillary	10.0
526	body mass index quantitative trait locus 11	10.0
527	body mass index quantitative trait locus 9	10.0
528	body mass index quantitative trait locus 8	10.0
529	hypotrichosis 7	10.0
530	abdominal obesity-metabolic syndrome 1	10.0
531	body mass index quantitative trait locus 4	10.0
532	body mass index quantitative trait locus 10	10.0
533	neutrophilic dermatosis, acute febrile	10.0
534	body mass index quantitative trait locus 7	10.0
535	body mass index quantitative trait locus 12	10.0
536	body mass index quantitative trait locus 14	10.0
537	corneal dystrophy, posterior amorphous	10.0
538	body mass index quantitative trait locus 18	10.0
539	body mass index quantitative trait locus 19	10.0
540	body mass index quantitative trait locus 20	10.0
541	chronic ulcer of skin	10.0
542	angina pectoris	10.0
543	henoch-schoenlein purpura	10.0
544	pertussis	10.0
545	cardiovascular system disease	10.0
546	papilloma	10.0
547	hyper ige recurrent infection syndrome 1	10.0
548	turner syndrome	10.0
549	mastocytosis	10.0
550	wheat allergy	10.0
551	hypotrichosis	10.0
552	atrophic gastritis	10.0
553	functional neutrophil defect	10.0
554	breast cancer	10.0
555	kaposi sarcoma	10.0
556	leukemia, chronic lymphocytic	10.0
557	autism	10.0
558	langerhans cell histiocytosis	10.0
559	intraocular pressure quantitative trait locus	10.0
560	kawasaki disease	10.0
561	immunoglobulin alpha deficiency	10.0
562	neutropenia	10.0
563	juvenile rheumatoid arthritis	10.0
564	b-cell lymphoma	10.0
565	hyperthyroidism	10.0
566	actinic keratosis	10.0
567	demodicidosis	10.0
568	glucagonoma	10.0
569	granulomatous rosacea	10.0
570	shwartzman phenomenon	10.0
571	alopecia, androgenetic, 1	10.0
572	hashimoto thyroiditis	10.0
573	hyper-ige recurrent infection syndrome 1, autosomal dominant	10.0
574	contractures, pterygia, and spondylocarpotarsal fusion syndrome 1a	10.0
575	neuraminidase deficiency	10.0
576	toe syndactyly, telecanthus, and anogenital and renal malformations	10.0
577	stroke, ischemic	10.0
578	leukemia, chronic myeloid	10.0
579	erythema nodosum	10.0
580	protein-losing enteropathy	10.0
581	interstitial nephritis	10.0
582	thrombocytopenia	10.0
583	myeloproliferative neoplasm	10.0
584	lipid metabolism disorder	10.0
585	t-cell adult acute lymphocytic leukemia	10.0
586	wells syndrome	10.0
587	lichen amyloidosis	10.0
588	pigmentation anomaly of the skin	10.0
589	keloid disorder	10.0
590	dentinogenesis imperfecta 1	10.0
591	nail disorder, nonsyndromic congenital, 1	10.0
592	osteoporosis	10.0
593	thrombophilia due to thrombin defect	10.0
594	hyper-ige recurrent infection syndrome 2, autosomal recessive	10.0
595	myeloma, multiple	10.0
596	lymphoma, non-hodgkin, familial	10.0
597	nasopharyngeal carcinoma	10.0
598	aplastic anemia	10.0
599	leukemia, acute lymphoblastic	10.0
600	immunodeficiency, common variable, 10	10.0
601	androgenic alopecia	10.0
602	biotin deficiency	10.0
603	hereditary lymphedema i	10.0
604	lyme disease	10.0
605	nephrotic syndrome	10.0
606	miliaria	10.0
607	polyneuropathy	10.0
608	disease of mental health	10.0
609	thrombocytopenia due to platelet alloimmunization	10.0
610	hepatitis	10.0
611	pharyngitis	10.0
612	hematologic cancer	10.0
613	mood disorder	10.0
614	hypertrichosis	10.0
615	myopathy	10.0
616	eye disease	10.0
617	lung disease	10.0
618	encephalitis	10.0
619	tenosynovitis	10.0
620	polyarteritis nodosa	10.0
621	periodontal ehlers-danlos syndrome	10.0
622	guttate psoriasis	10.0
623	splenomegaly	10.0
624	dock8 immunodeficiency syndrome	10.0
625	bullous impetigo	10.0
626	hirschsprung disease 1	9.9
627	neutrophilia, hereditary	9.9
628	varicose veins	9.9
629	volvulus of midgut	9.9
630	glycogen storage disease v	9.9
631	congenital disorder of glycosylation, type iic	9.9
632	leukemia, acute myeloid	9.9
633	spastic paraplegia, ataxia, and mental retardation	9.9
634	myocardial infarction	9.9
635	bone mineral density quantitative trait locus 8	9.9
636	trichotillomania	9.9
637	bone mineral density quantitative trait locus 15	9.9
638	psoriasis 14, pustular	9.9
639	vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	9.9
640	anaplastic large cell lymphoma	9.9
641	autosomal recessive congenital ichthyosis	9.9
642	non-alcoholic fatty liver disease	9.9
643	tonsillitis	9.9
644	familial hyperlipidemia	9.9
645	ecthyma	9.9
646	excessive tearing	9.9
647	factitious disorder	9.9
648	hepatitis c	9.9
649	iron metabolism disease	9.9
650	myelitis	9.9
651	collecting duct carcinoma	9.9
652	infertility	9.9
653	spondylitis	9.9
654	diffuse idiopathic skeletal hyperostosis	9.9
655	septic arthritis	9.9
656	periodontitis	9.9
657	myeloid leukemia	9.9
658	acute graft versus host disease	9.9
659	alopecia totalis	9.9
660	erythrokeratoderma ''en cocardes''	9.9
661	granulocytopenia	9.9
662	oral lichen planus	9.9
663	gastroesophageal reflux	9.9
664	darier-white disease	9.9
665	hypercholesterolemia, familial, 1	9.9
666	laryngeal abductor paralysis	9.9
667	mastocytosis, cutaneous	9.9
668	obsessive-compulsive disorder	9.9
669	scleroderma, familial progressive	9.9
670	myasthenia gravis	9.9
671	helicobacter pylori infection	9.9
672	anterior segment dysgenesis 3	9.9
673	pulmonary disease, chronic obstructive	9.9
674	hepatitis c virus	9.9
675	lung cancer susceptibility 3	9.9
676	congenital lipomatous overgrowth, vascular malformations, and epidermal nevi	9.9
677	fetal encasement syndrome	9.9
678	intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies	9.9
679	ptosis	9.9
680	angular cheilitis	9.9
681	combined immunodeficiency	9.9
682	lactose intolerance	9.9
683	microcephaly	9.9
684	pulpitis	9.9
685	vitamin k deficiency bleeding	9.9
686	tinea corporis	9.9
687	primary biliary cholangitis	9.9
688	retinal perforation	9.9
689	coccidioidomycosis	9.9
690	hepatitis b	9.9
691	ectodermal dysplasia	9.9
692	thrombocytosis	9.9
693	acute kidney failure	9.9
694	chronic granulomatous disease	9.9
695	intestinal disease	9.9
696	hemolytic anemia	9.9
697	impetigo herpetiformis	9.9
698	lichen nitidus	9.9
699	lymphangitis	9.9
700	fasciitis	9.9
701	hemorrhoid	9.9
702	stat3 hyper ige syndrome	9.9
703	catastrophic antiphospholipid syndrome	9.9
704	cryopyrin-associated periodic syndrome	9.9
705	frontal fibrosing alopecia	9.9
706	papular urticaria	9.9
707	headache	9.9
708	acute generalized exanthematous pustulosis	9.9
709	apert syndrome	9.9
710	amyloidosis, primary localized cutaneous, 1	9.9
711	adermatoglyphia	9.9
712	muir-torre syndrome	9.9
713	iga nephropathy 1	9.9
714	benign chronic pemphigus	9.9
715	pityriasis rubra pilaris	9.9
716	thrombocytopenic purpura, autoimmune	9.9
717	vitreoretinopathy, neovascular inflammatory	9.9
718	enterocolitis	9.9
719	xeroderma pigmentosum, variant type	9.9
720	bazex syndrome	9.9
721	premature ovarian failure 7	9.9
722	nail disorder, nonsyndromic congenital, 9	9.9
723	membranous nephropathy	9.9
724	corticosteroid allergy	9.9
725	diffuse large b-cell lymphoma	9.9
726	peripheral t-cell lymphoma	9.9
727	polymyositis	9.9
728	parkinsonism	9.9
729	hypopyon	9.9
730	borderline personality disorder	9.9
731	gestational diabetes	9.9
732	conn's syndrome	9.9
733	gout	9.9
734	porphyria	9.9
735	skin sarcoidosis	9.9
736	kwashiorkor	9.9
737	anterior uveitis	9.9
738	adult-onset still's disease	9.9
739	cholinergic urticaria	9.9
740	hypersensitivity reaction type iii disease	9.9
741	ectropion	9.9
742	endogenous depression	9.9
743	cystitis	9.9
744	rectal benign neoplasm	9.9
745	dental caries	9.9
746	iga glomerulonephritis	9.9
747	gingivitis	9.9
748	keratoacanthoma	9.9
749	bone inflammation disease	9.9
750	mammary paget's disease	9.9
751	pulmonary fibrosis	9.9
752	arthropathy	9.9
753	thrombophlebitis	9.9
754	secondary syphilis	9.9
755	epidermolysis bullosa acquisita	9.9
756	pancreatitis	9.9
757	lice infestation	9.9
758	kidney disease	9.9
759	peripheral nervous system disease	9.9
760	reactive arthritis	9.9
761	transient hypogammaglobulinemia	9.9
762	cerebrovascular disease	9.9
763	myocarditis	9.9
764	collagen disease	9.9
765	rubella	9.9
766	cholangitis	9.9
767	irritable bowel syndrome	9.9
768	bowen's disease	9.9
769	gianotti crosti syndrome	9.9
770	pyogenic granuloma	9.9
771	systemic onset juvenile idiopathic arthritis	9.9
772	whiplash	9.9
773	posttransplant acute limbic encephalitis	9.9
774	argyria	9.9
775	chronic bilirubin encephalopathy	9.9
776	solar urticaria	9.9
777	vitreoretinopathy	9.9
778	polyendocrinopathy	9.9
779	twin-reversed arterial perfusion sequence	9.9
780	complement component 3 deficiency, autosomal recessive	9.8
781	sick building syndrome	9.8
782	junctional epidermolysis bullosa	9.8
783	complement component 3 deficiency	9.8
784	premature aging	9.8
785	lichen disease	9.8
786	apnea, obstructive sleep	9.8
787	leukemia, chronic lymphocytic 2	9.8
788	carpal tunnel syndrome	9.8
789	factor viii deficiency	9.8
790	guillain-barre syndrome, familial	9.8
791	hair whorl	9.8
792	porokeratosis 2, palmar, plantar, and disseminated type	9.8
793	raynaud disease	9.8
794	split-hand/foot malformation 1	9.8
795	digeorge syndrome	9.8
796	tobacco addiction	9.8
797	ataxia-telangiectasia	9.8
798	charge syndrome	9.8
799	choroidal dystrophy, central areolar, 1	9.8
800	pancreatic cancer	9.8
801	reticulum cell sarcoma	9.8
802	multiple congenital anomalies-neurodevelopmental syndrome, x-linked	9.8
803	ichthyosis, x-linked	9.8
804	incontinentia pigmenti	9.8
805	prostate cancer/brain cancer susceptibility	9.8
806	sickle cell anemia	9.8
807	bone mineral density quantitative trait locus 3	9.8
808	hypereosinophilic syndrome, idiopathic	9.8
809	pontocerebellar hypoplasia, type 3	9.8
810	chromosome 22q11.2 deletion syndrome, distal	9.8
811	mononeuropathy of the median nerve, mild	9.8
812	cholangitis, primary sclerosing	9.8
813	cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	9.8
814	pulmonary fibrosis and/or bone marrow failure, telomere-related, 2	9.8
815	short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	9.8
816	peripheral vascular disease	9.8
817	female breast cancer	9.8
818	sleep apnea	9.8
819	alexithymia	9.8
820	erythema elevatum diutinum	9.8
821	melanoma in congenital melanocytic nevus	9.8
822	chronic myelomonocytic leukemia	9.8
823	paraneoplastic pemphigus	9.8
824	severe covid-19	9.8
825	split hand-foot malformation	9.8
826	osteonecrosis	9.8
827	t cell deficiency	9.8
828	common variable immunodeficiency	9.8
829	leukemia	9.8
830	pancytopenia	9.8
831	dementia	9.8
832	urethritis	9.8
833	cholestasis	9.8
834	childhood type dermatomyositis	9.8
835	oral candidiasis	9.8
836	sclerosing cholangitis	9.8
837	glossitis	9.8
838	dermatomycosis	9.8
839	pericarditis	9.8
840	islet cell tumor	9.8
841	impotence	9.8
842	rectum cancer	9.8
843	hemangioma	9.8
844	larynx cancer	9.8
845	synovitis	9.8
846	acute pancreatitis	9.8
847	antiphospholipid syndrome	9.8
848	facial dermatosis	9.8
849	necrobiosis lipoidica	9.8
850	vulvitis	9.8
851	tinea capitis	9.8
852	poliomyelitis	9.8
853	epidermolysis bullosa dystrophica	9.8
854	neurotic disorder	9.8
855	liver cirrhosis	9.8
856	peptic ulcer disease	9.8
857	interdigitating dendritic cell sarcoma	9.8
858	osteoarthritis	9.8
859	polycythemia	9.8
860	reticulosarcoma	9.8
861	eating disorder	9.8
862	learning disability	9.8
863	ocular hypertension	9.8
864	cleft lip	9.8
865	pulmonary embolism	9.8
866	follicular mucinosis	9.8
867	acute myeloid leukemia with recurrent genetic anomaly	9.8
868	enteropathy-associated t-cell lymphoma	9.8
869	klebsiella infection	9.8
870	lichen planus pigmentosus	9.8
871	mycobacterium kansasii	9.8
872	pdgfrb-associated chronic eosinophilic leukemia	9.8
873	paraneoplastic syndromes	9.8
874	subacute cutaneous lupus erythematosus	9.8
875	cleft lip/palate	9.8
876	cerebrofacial arteriovenous metameric syndrome	9.8
877	isolated split hand-split foot malformation	9.8
878	gastritis, familial giant hypertrophic	9.8
879	motion sickness	9.8
880	nephrolithiasis, calcium oxalate	9.8
881	prediabetes syndrome	9.8
882	tic disorder	9.8
883	intracranial hypertension	9.8
884	pfeiffer syndrome	9.8
885	anal canal carcinoma	9.8
886	atherosclerosis susceptibility	9.8
887	carcinoid tumors, intestinal	9.8
888	ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 1	9.8
889	hypertension, essential	9.8
890	lentigines	9.8
891	melkersson-rosenthal syndrome	9.8
892	migraine with or without aura 1	9.8
893	nevus, epidermal	9.8
894	pachyonychia congenita 1	9.8
895	protoporphyria, erythropoietic, 1	9.8
896	spondylosis, cervical	9.8
897	stiff-person syndrome	9.8
898	albinism, oculocutaneous, type ii	9.8
899	fetal akinesia deformation sequence 1	9.8
900	epidermodysplasia verruciformis 1	9.8
901	hypoadrenocorticism, familial	9.8
902	papillon-lefevre syndrome	9.8
903	maple syrup urine disease	9.8
904	spondylometaphyseal dysplasia, sedaghatian type	9.8
905	nijmegen breakage syndrome	9.8
906	3-methylglutaconic aciduria, type iii	9.8
907	imerslund-grasbeck syndrome 1	9.8
908	hemophagocytic lymphohistiocytosis, familial, 1	9.8
909	short syndrome	9.8
910	testicular germ cell tumor	9.8
911	anemia, sideroblastic, 1	9.8
912	lymphoproliferative syndrome, x-linked, 1	9.8
913	gallbladder disease 1	9.8
914	scheie syndrome	9.8
915	granulomatosis with polyangiitis	9.8
916	alzheimer disease 12	9.8
917	acute promyelocytic leukemia	9.8
918	gastric cancer	9.8
919	microcephaly, epilepsy, and diabetes syndrome 1	9.8
920	olmsted syndrome 1	9.8
921	aortic valve disease 2	9.8
922	human herpesvirus 8	9.8
923	leptin receptor deficiency	9.8
924	fetal akinesia deformation sequence 2	9.8
925	fetal akinesia deformation sequence 3	9.8
926	t-cell lymphoma, subcutaneous panniculitis-like	9.8
927	hypoalphalipoproteinemia, primary, 2	9.8
928	hypertrophic scars	9.8
929	vitamin b12 deficiency	9.8
930	ductal carcinoma in situ	9.8
931	thrombosis	9.8
932	bone disease	9.8
933	mutilating palmoplantar keratoderma with periorificial keratotic plaques	9.8
934	corneal disease	9.8
935	mumps	9.8
936	pre-eclampsia	9.8
937	glucose intolerance	9.8
938	gastric ulcer	9.8
939	dirofilariasis	9.8
940	lepromatous leprosy	9.8
941	common wart	9.8
942	anogenital venereal wart	9.8
943	disseminated intravascular coagulation	9.8
944	adult respiratory distress syndrome	9.8
945	autonomic nervous system disease	9.8
946	protein-energy malnutrition	9.8
947	male infertility	9.8
948	graves' disease	9.8
949	bronchopneumonia	9.8
950	cicatricial ectropion	9.8
951	conduct disorder	9.8
952	brain cancer	9.8
953	reading disorder	9.8
954	megaloblastic anemia	9.8
955	patent foramen ovale	9.8
956	interstitial cystitis	9.8
957	viral hepatitis	9.8
958	telogen effluvium	9.8
959	autoimmune hepatitis	9.8
960	spondylosis	9.8
961	keratopathy	9.8
962	sensory peripheral neuropathy	9.8
963	endometriosis	9.8
964	cryoglobulinemia	9.8
965	pulmonary tuberculosis	9.8
966	bursitis	9.8
967	gingival overgrowth	9.8
968	proctitis	9.8
969	plague	9.8
970	acute retinal necrosis syndrome	9.8
971	retinitis	9.8
972	aortic aneurysm	9.8
973	merkel cell carcinoma	9.8
974	mouth disease	9.8
975	pancreatic adenocarcinoma	9.8
976	liver disease	9.8
977	erythrasma	9.8
978	superficial basal cell carcinoma	9.8
979	burning mouth syndrome	9.8
980	intracranial embolism	9.8
981	epidermolysis bullosa simplex	9.8
982	somatoform disorder	9.8
983	demyelinating polyneuropathy	9.8
984	pediculus humanus capitis infestation	9.8
985	paraplegia	9.8
986	transient hypogammaglobulinemia of infancy	9.8
987	inflammatory breast carcinoma	9.8
988	chronic kidney disease	9.8
989	mediastinitis	9.8
990	influenza	9.8
991	actinomycosis	9.8
992	scarlet fever	9.8
993	skin melanoma	9.8
994	diabetes mellitus	9.8
995	fatty liver disease	9.8
996	postpartum depression	9.8
997	bronchiectasis	9.8
998	yellow fever	9.8
999	bacterial conjunctivitis	9.8
1000	sickle cell disease	9.8
1001	carcinoid syndrome	9.8
1002	cutis verticis gyrata	9.8
1003	haemophilus influenzae	9.8
1004	herpes simplex encephalitis	9.8
1005	pityriasis lichenoides	9.8
1006	scleromyxedema	9.8
1007	cerebral aneurysms	9.8
1008	erythema multiforme major	9.8
1009	pemphigus erythematosus	9.8
1010	epidermal disease	9.8
1011	epithelial recurrent erosion dystrophy	9.7
1012	maturity-onset diabetes of the young, type 1	9.7
1013	lymphoma, mucosa-associated lymphoid type	9.7
1014	hypercalciuria, absorptive, 2	9.7
1015	hutchinson-gilford progeria syndrome	9.7
1016	wilms tumor 1	9.7
1017	farber lipogranulomatosis	9.7
1018	cartilage-hair hypoplasia	9.7
1019	xeroderma pigmentosum, complementation group a	9.7
1020	wilms tumor 5	9.7
1021	propionic acidemia	9.7
1022	immunodeficiency 35	9.7
1023	adiponectin, serum level of, quantitative trait locus 1	9.7
1024	osteomyelitis, sterile multifocal, with periostitis and pustulosis	9.7
1025	gaba aminotransferase deficiency	9.7
1026	yaws	9.7
1027	acute laryngopharyngitis	9.7
1028	cartilage disease	9.7
1029	hypolipoproteinemia	9.7
1030	biliary tract cancer	9.7
1031	cartilage-hair hypoplasia - anauxetic dysplasia spectrum disorders	9.7
1032	hypomyelination of early myelinating structures	9.7
1033	autoinflammatory syndrome	9.7
1034	aortic aneurysm, familial abdominal, 1	9.7
1035	amyotrophic lateral sclerosis 1	9.7
1036	ankyloblepharon-ectodermal defects-cleft lip/palate	9.7
1037	coloboma, ocular, autosomal dominant	9.7
1038	dentin dysplasia, type i	9.7
1039	type 2 diabetes mellitus	9.7
1040	multiple sclerosis	9.7
1041	dupuytren contracture	9.7
1042	rapp-hodgkin syndrome	9.7
1043	epidermoid cysts	9.7
1044	esophageal cancer	9.7
1045	immunoglobulin a deficiency 1	9.7
1046	hypertriglyceridemia 1	9.7
1047	inclusion body myositis	9.7
1048	intussusception	9.7
1049	lipomatosis, multiple	9.7
1050	capillary malformations, congenital	9.7
1051	ovarian cancer	9.7
1052	paget disease, extramammary	9.7
1053	pectus excavatum	9.7
1054	periodontitis, aggressive, 1	9.7
1055	pheochromocytoma	9.7
1056	polykaryocytosis inducer	9.7
1057	variegate porphyria	9.7
1058	keratosis, seborrheic	9.7
1059	small cell cancer of the lung	9.7
1060	temporal arteritis	9.7
1061	thrombocythemia 1	9.7
1062	trichomegaly	9.7
1063	adrenocortical carcinoma, hereditary	9.7
1064	anemia, autoimmune hemolytic	9.7
1065	apolipoprotein c-ii deficiency	9.7
1066	deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures syndrome	9.7
1067	dubowitz syndrome	9.7
1068	eosinophilic fasciitis	9.7
1069	ichthyosis, congenital, autosomal recessive 1	9.7
1070	ichthyosis, congenital, autosomal recessive 4b	9.7
1071	intracranial hypertension, idiopathic	9.7
1072	jawad syndrome	9.7
1073	mucolipidosis iv	9.7
1074	myelofibrosis	9.7
1075	ocular motor apraxia	9.7
1076	chronic recurrent multifocal osteomyelitis	9.7
1077	phenylketonuria	9.7
1078	isolated growth hormone deficiency, type ia	9.7
1079	pituitary hormone deficiency, combined, 2	9.7
1080	pseudoxanthoma elasticum	9.7
1081	peeling skin syndrome 1	9.7
1082	insulin-like growth factor i	9.7
1083	spastic ataxia, charlevoix-saguenay type	9.7
1084	arts syndrome	9.7
1085	aging	9.7
1086	suppression of tumorigenicity 12	9.7
1087	psoriasis 3	9.7
1088	hyperinsulinemic hypoglycemia, familial, 2	9.7
1089	xanthomatosis	9.7
1090	psoriasis 4	9.7
1091	aceruloplasminemia	9.7
1092	anorexia nervosa	9.7
1093	bulimia nervosa	9.7
1094	dermatofibrosarcoma protuberans	9.7
1095	celiac disease 2	9.7
1096	cone-rod synaptic disorder, congenital nonprogressive	9.7
1097	pulmonary alveolar proteinosis, acquired	9.7
1098	congenital disorder of glycosylation, type in	9.7
1099	hearing loss, noise-induced	9.7
1100	alpha-1-antitrypsin deficiency	9.7
1101	hemorrhage, intracerebral	9.7
1102	steel syndrome	9.7
1103	spastic paraplegia, intellectual disability, nystagmus, and obesity	9.7
1104	angiosarcoma	9.7
1105	erysipeloid	9.7
1106	hemophagocytic lymphohistiocytosis	9.7
1107	tungiasis	9.7
1108	seckel syndrome	9.7
1109	chorioamnionitis	9.7
1110	marginal zone b-cell lymphoma	9.7
1111	atrioventricular block	9.7
1112	oral squamous cell carcinoma	9.7
1113	withdrawal disorder	9.7
1114	interleukin-7 receptor alpha deficiency	9.7
1115	sexual health disorder	9.7
1116	pain agnosia	9.7
1117	body dysmorphic disorder	9.7
1118	ileitis	9.7
1119	cardiac arrest	9.7
1120	zika fever	9.7
1121	cutaneous candidiasis	9.7
1122	b-lymphoblastic leukemia/lymphoma	9.7
1123	nk cell deficiency	9.7
1124	transverse myelitis	9.7
1125	diffuse gastric cancer	9.7
1126	human cytomegalovirus infection	9.7
1127	b-cell prolymphocytic leukemia	9.7
1128	central diabetes insipidus	9.7
1129	isolated ectopia lentis	9.7
1130	castleman disease	9.7
1131	psoriasis 15	9.7
1132	familial isolated trichomegaly	9.7
1133	pigmentation disease	9.7
1134	dry eye syndrome	9.7
1135	tuberculoid leprosy	9.7
1136	prolymphocytic leukemia	9.7
1137	bacterial infectious disease	9.7
1138	osteomalacia	9.7
1139	allergic urticaria	9.7
1140	open-angle glaucoma	9.7
1141	hypertrophy of breast	9.7
1142	giardiasis	9.7
1143	multiple personality disorder	9.7
1144	myiasis	9.7
1145	miliaria rubra	9.7
1146	acute conjunctivitis	9.7
1147	angelucci's syndrome	9.7
1148	arteriovenous malformation	9.7
1149	pneumocystosis	9.7
1150	limb-girdle muscular dystrophy	9.7
1151	iron deficiency anemia	9.7
1152	multicentric reticulohistiocytosis	9.7
1153	myopia	9.7
1154	visual epilepsy	9.7
1155	peripheral retinal degeneration	9.7
1156	goiter	9.7
1157	punctate epithelial keratoconjunctivitis	9.7
1158	vulva cancer	9.7
1159	secondary hyperparathyroidism	9.7
1160	bell's palsy	9.7
1161	acute kidney tubular necrosis	9.7
1162	olecranon bursitis	9.7
1163	ancylostomiasis	9.7
1164	guillain-barre syndrome	9.7
1165	hypochondriasis	9.7
1166	dilated cardiomyopathy	9.7
1167	tinea unguium	9.7
1168	ehlers-danlos syndrome	9.7
1169	hyperparathyroidism	9.7
1170	sick sinus syndrome	9.7
1171	somatization disorder	9.7
1172	amenorrhea	9.7
1173	autoimmune polyendocrine syndrome	9.7
1174	anus cancer	9.7
1175	bacteriuria	9.7
1176	dumping syndrome	9.7
1177	geographic tongue	9.7
1178	root resorption	9.7
1179	cholera	9.7
1180	rheumatic fever	9.7
1181	heart septal defect	9.7
1182	endocrine gland cancer	9.7
1183	histoplasmosis	9.7
1184	status epilepticus	9.7
1185	epilepsy	9.7
1186	cholecystitis	9.7
1187	cerebral palsy	9.7
1188	hyperinsulinism	9.7
1189	atypical teratoid rhabdoid tumor	9.7
1190	vaginitis	9.7
1191	carbuncle	9.7
1192	essential thrombocythemia	9.7
1193	vulvovaginitis	9.7
1194	lateral sclerosis	9.7
1195	polyclonal hypergammaglobulinemia	9.7
1196	arteriosclerosis	9.7
1197	relapsing-remitting multiple sclerosis	9.7
1198	neonatal jaundice	9.7
1199	splenic infarction	9.7
1200	relapsing polychondritis	9.7
1201	laryngeal benign neoplasm	9.7
1202	benign mesothelioma	9.7
1203	capillary hemangioma	9.7
1204	hemoglobinopathy	9.7
1205	adenocarcinoma	9.7
1206	germ cell cancer	9.7
1207	testicular cancer	9.7
1208	breast ductal carcinoma	9.7
1209	substance abuse	9.7
1210	cutis laxa	9.7
1211	skin squamous cell carcinoma	9.7
1212	monkeypox	9.7
1213	bipolar disorder	9.7
1214	fibrosarcoma	9.7
1215	signet ring cell adenocarcinoma	9.7
1216	toxic encephalopathy	9.7
1217	plasmacytoma	9.7
1218	anovulation	9.7
1219	pleural empyema	9.7
1220	porokeratosis	9.7
1221	lung squamous cell carcinoma	9.7
1222	angioma serpiginosum	9.7
1223	primary syphilis	9.7
1224	hyperglycemia	9.7
1225	polyradiculoneuropathy	9.7
1226	pustulosis of palm and sole	9.7
1227	cutaneous fibrous histiocytoma	9.7
1228	seminoma	9.7
1229	proliferative glomerulonephritis	9.7
1230	movement disease	9.7
1231	esophagus adenocarcinoma	9.7
1232	chronic inflammatory demyelinating polyradiculoneuropathy	9.7
1233	human immunodeficiency virus infectious disease	9.7
1234	hydrarthrosis	9.7
1235	anal squamous cell carcinoma	9.7
1236	compartment syndrome	9.7
1237	premenstrual tension	9.7
1238	muscular atrophy	9.7
1239	neuroblastoma	9.7
1240	appendicitis	9.7
1241	corneal ulcer	9.7
1242	retinal degeneration	9.7
1243	whipple disease	9.7
1244	mucormycosis	9.7
1245	monocytic leukemia	9.7
1246	chronic fatigue syndrome	9.7
1247	multiple carboxylase deficiency	9.7
1248	duodenitis	9.7
1249	gastroduodenitis	9.7
1250	genital herpes	9.7
1251	diabetes insipidus	9.7
1252	babesiosis	9.7
1253	neonatal abstinence syndrome	9.7
1254	refractive error	9.7
1255	meibomian cyst	9.7
1256	hypoglycemia	9.7
1257	actinic lichen planus	9.7
1258	aminoaciduria	9.7
1259	bowenoid papulosis	9.7
1260	chronic graft versus host disease	9.7
1261	cutaneous sclerosis	9.7
1262	grover's disease	9.7
1263	inflammatory linear verrucous epidermal nevus	9.7
1264	lip and oral cavity cancer	9.7
1265	mycobacterium marinum	9.7
1266	neonatal systemic lupus erythematosus	9.7
1267	progressive encephalomyelitis with rigidity and myoclonus	9.7
1268	pyridoxine deficiency	9.7
1269	staphylococcal toxic shock syndrome	9.7
1270	encephalopathy	9.7
1271	pituitary tumors	9.7
1272	syncope	9.7
1273	folliculotropic mycosis fungoides	9.7
1274	systemic autoimmune disease	9.7
1275	primary cutaneous lymphoma	9.7
1276	germ cell tumor	9.7
1277	acquired cutis laxa	9.7
1278	diffuse palmoplantar keratoderma	9.7
1279	primary cutaneous anaplastic large cell lymphoma	9.7
1280	neonatal lupus erythematosus	9.7
1281	acquired ichthyosis	9.7
1282	rare genetic skin disease	9.7
1283	inherited epidermolysis bullosa	9.7
1284	heiner syndrome	9.7
1285	precursor t-cell acute lymphoblastic leukemia	9.7
1286	aniridia 1	9.6
1287	preauricular fistulae, congenital	9.6
1288	multiple endocrine neoplasia, type i	9.6
1289	eosinophilia, familial	9.6
1290	heinz body anemias	9.6
1291	keratitis-ichthyosis-deafness syndrome, autosomal dominant	9.6
1292	cyclic neutropenia	9.6
1293	paget disease of bone 3	9.6
1294	palatopharyngeal incompetence	9.6
1295	velocardiofacial syndrome	9.6
1296	schopf-schulz-passarge syndrome	9.6
1297	galactorrhea	9.6
1298	glaucoma 3, primary congenital, a	9.6
1299	ciliary dyskinesia, primary, 1	9.6
1300	letterer-siwe disease	9.6
1301	shwachman-diamond syndrome 1	9.6
1302	spondyloepimetaphyseal dysplasia, sponastrime type	9.6
1303	anemia, sideroblastic, and spinocerebellar ataxia	9.6
1304	menkes disease	9.6
1305	reticuloendotheliosis, x-linked	9.6
1306	rett syndrome	9.6
1307	cervical cancer	9.6
1308	resting heart rate, variation in	9.6
1309	mycobacterium tuberculosis 1	9.6
1310	lipodystrophy, congenital generalized, type 1	9.6
1311	thiopurines, poor metabolism of, 1	9.6
1312	hyperprolactinemia	9.6
1313	lung disease, immunodeficiency, and chromosome breakage syndrome	9.6
1314	shrimp allergy	9.6
1315	oxirane allergy	9.6
1316	kartagener syndrome	9.6
1317	brugada syndrome	9.6
1318	oculocutaneous albinism	9.6
1319	spondyloepimetaphyseal dysplasia	9.6
1320	urolithiasis	9.6
1321	lactocele	9.6
1322	meningocele	9.6
1323	obsessive-compulsive personality disorder	9.6
1324	bullous keratopathy	9.6
1325	horner's syndrome	9.6
1326	hepatorenal syndrome	9.6
1327	blastomycosis	9.6
1328	klebsiella pneumonia	9.6
1329	hepatic encephalopathy	9.6
1330	eclampsia	9.6
1331	pthirus pubis infestation	9.6
1332	prostatitis	9.6
1333	branchiootorenal syndrome	9.6
1334	arthus reaction	9.6
1335	clear cell acanthoma	9.6
1336	duodenal ulcer	9.6
1337	acanthoma	9.6
1338	tularemia	9.6
1339	acromegaly	9.6
1340	hemangioma of liver	9.6
1341	carbohydrate metabolic disorder	9.6
1342	bacterial vaginosis	9.6
1343	insulinoma	9.6
1344	femoral neuropathy	9.6
1345	hair disease	9.6
1346	skin angiosarcoma	9.6
1347	subacute bacterial endocarditis	9.6
1348	atrophic rhinitis	9.6
1349	paget's disease of bone	9.6
1350	nephrolithiasis	9.6
1351	viral encephalitis	9.6
1352	mitochondrial myopathy	9.6
1353	monoclonal gammopathy of uncertain significance	9.6
1354	situs inversus	9.6
1355	pyomyositis	9.6
1356	intermediate coronary syndrome	9.6
1357	amebiasis	9.6
1358	amino acid metabolic disorder	9.6
1359	homocystinuria	9.6
1360	primary ciliary dyskinesia	9.6
1361	necrotizing fasciitis	9.6
1362	steroid-induced glaucoma	9.6
1363	tp63-related disorders	9.6
1364	49,xxxxx syndrome	9.6
1365	albinism	9.6
1366	cervical intraepithelial neoplasia	9.6
1367	congenital herpes simplex	9.6
1368	cytomegalic inclusion disease	9.6
1369	dextrocardia with situs inversus	9.6
1370	ichthyosis linearis circumflexa	9.6
1371	immunoglobulin g deficiency	9.6
1372	preauricular sinus	9.6
1373	rare tumor of pancreas	9.6
1374	inherited ichthyosis	9.6
1375	inflammatory myopathy with abundant macrophages	9.6
1376	lmna-related cardiocutaneous progeria syndrome	9.6
1377	hyperpigmentation of the skin	9.6
1378	microtia	9.6
1379	abducens palsy	9.5
1380	acanthosis nigricans	9.5
1381	acromegaloid changes, cutis verticis gyrata, and corneal leukoma	9.5
1382	severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency	9.5
1383	ainhum	9.5
1384	diamond-blackfan anemia 1	9.5
1385	arteries, anomalies of	9.5
1386	aortic valve disease 1	9.5
1387	bladder cancer	9.5
1388	epidermolytic hyperkeratosis	9.5
1389	campomelic dysplasia	9.5
1390	cleft palate, isolated	9.5
1391	blepharocheilodontic syndrome 1	9.5
1392	coloboma of macula	9.5
1393	coloboma of optic nerve	9.5
1394	craniofacial-deafness-hand syndrome	9.5
1395	cryoglobulinemia, familial mixed	9.5
1396	epidermolysis bullosa dystrophica, autosomal dominant	9.5
1397	epidermolysis bullosa simplex 1a, generalized severe	9.5
1398	erythrokeratodermia variabilis et progressiva 1	9.5
1399	fibrinolytic defect	9.5
1400	fibrodysplasia ossificans progressiva	9.5
1401	fucosidase regulator	9.5
1402	melanocytic nevus syndrome, congenital	9.5
1403	glioma susceptibility 1	9.5
1404	hair morphology 2	9.5
1405	hawkinsinuria	9.5
1406	palmoplantar keratoderma, epidermolytic	9.5
1407	endosteal hyperostosis, autosomal dominant	9.5
1408	hypertelorism	9.5
1409	keloid formation	9.5
1410	legg-calve-perthes disease	9.5
1411	leopard syndrome 1	9.5
1412	leukemia, acute monocytic	9.5
1413	nail disorder, nonsyndromic congenital, 3	9.5
1414	macular dystrophy, dominant cystoid	9.5
1415	marfan syndrome	9.5
1416	medulloblastoma	9.5
1417	melanoma, uveal	9.5
1418	melanoma-astrocytoma syndrome	9.5
1419	meniere disease	9.5
1420	mesothelioma, malignant	9.5
1421	naegeli-franceschetti-jadassohn syndrome	9.5
1422	nail-patella syndrome	9.5
1423	narcolepsy 1	9.5
1424	neurofibromatosis, type i	9.5
1425	schimmelpenning-feuerstein-mims syndrome	9.5
1426	noonan syndrome 1	9.5
1427	ocular cicatricial pemphigoid	9.5
1428	spinocerebellar ataxia 1	9.5
1429	pancreatitis, hereditary	9.5
1430	papillomatosis, confluent and reticulated	9.5
1431	paragangliomas 1	9.5
1432	prolidase deficiency	9.5
1433	pick disease of brain	9.5
1434	polydactyly, postaxial, type a1	9.5
1435	popliteal cyst	9.5
1436	porphyria, acute intermittent	9.5
1437	prostate cancer	9.5
1438	liddle syndrome 1	9.5
1439	pulmonary hemosiderosis	9.5
1440	pulmonary hypertension, primary, 1	9.5
1441	pruritic urticarial papules and plaques of pregnancy	9.5
1442	aplasia of lacrimal and salivary glands	9.5
1443	scalp-ear-nipple syndrome	9.5
1444	neural tube defects	9.5
1445	spondylolisthesis	9.5
1446	steatocystoma multiplex	9.5
1447	strabismus	9.5
1448	sturge-weber syndrome	9.5
1449	supravalvular aortic stenosis	9.5
1450	chromosome 2q35 duplication syndrome	9.5
1451	thyroid cancer, nonmedullary, 1	9.5
1452	trichodentoosseous syndrome	9.5
1453	suppressor of tumorigenicity 3	9.5
1454	uncombable hair syndrome 1	9.5
1455	urticaria, aquagenic	9.5
1456	vasculitis, lymphocytic, nodular	9.5
1457	alkaptonuria	9.5
1458	takayasu arteritis	9.5
1459	arthrogryposis, renal dysfunction, and cholestasis 1	9.5
1460	central hypoventilation syndrome, congenital, 1	9.5
1461	cholestasis, progressive familial intrahepatic, 1	9.5
1462	c syndrome	9.5
1463	lung cancer	9.5
1464	joubert syndrome 1	9.5
1465	dyssynergia cerebellaris myoclonica of hunt	9.5
1466	chediak-higashi syndrome	9.5
1467	complement component 2 deficiency	9.5
1468	costello syndrome	9.5
1469	hypothyroidism, congenital, nongoitrous, 2	9.5
1470	ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive	9.5
1471	factor vii deficiency	9.5
1472	fanconi anemia, complementation group d2	9.5
1473	3-hydroxyacyl-coa dehydrogenase deficiency	9.5
1474	goodpasture syndrome	9.5
1475	factor xii deficiency	9.5
1476	trichothiodystrophy 4, nonphotosensitive	9.5
1477	halo nevi	9.5
1478	hartnup disorder	9.5
1479	hemochromatosis, type 1	9.5
1480	histidinemia	9.5
1481	hutterite cerebroosteonephrodysplasia syndrome	9.5
1482	hypogonadism, male	9.5
1483	acetylation, slow	9.5
1484	arima syndrome	9.5
1485	lipoid proteinosis of urbach and wiethe	9.5
1486	mucolipidosis ii alpha/beta	9.5
1487	lethal congenital contracture syndrome 1	9.5
1488	muscular dystrophy, limb-girdle, autosomal recessive 5	9.5
1489	myeloperoxidase deficiency	9.5
1490	myxedema	9.5
1491	gyrate atrophy of choroid and retina	9.5
1492	osteogenic sarcoma	9.5
1493	peters-plus syndrome	9.5
1494	glycogen storage disease ixb	9.5
1495	pili torti, early-onset	9.5
1496	scott syndrome	9.5
1497	polycythemia vera	9.5
1498	multiple pterygium syndrome, escobar variant	9.5
1499	autoimmune polyendocrine syndrome, type ii	9.5
1500	smith-lemli-opitz syndrome	9.5
1501	taurodontism	9.5
1502	thymoma, familial	9.5
1503	hypothyroidism, congenital, nongoitrous, 1	9.5
1504	tinea imbricata	9.5
1505	methylmalonic aciduria and homocystinuria, cblc type	9.5
1506	waardenburg syndrome, type 4a	9.5
1507	wilson disease	9.5
1508	woolly hair, hypotrichosis, everted lower lip, and outstanding ears	9.5
1509	coloboma, congenital heart disease, ichthyosiform dermatosis, mental retardation, and ear anomalies syndrome	9.5
1510	opitz gbbb syndrome	9.5
1511	fragile x syndrome	9.5
1512	chromosome xp21 deletion syndrome	9.5
1513	chondrodysplasia punctata 2, x-linked dominant	9.5
1514	aarskog-scott syndrome	9.5
1515	granulomatous disease, chronic, x-linked	9.5
1516	glycerol kinase deficiency	9.5
1517	hypogonadotropic hypogonadism 1 with or without anosmia	9.5
1518	linear skin defects with multiple congenital anomalies 1	9.5
1519	muscular dystrophy, duchenne type	9.5
1520	thoracoabdominal syndrome	9.5
1521	alzheimer disease mitochondrial	9.5
1522	kearns-sayre syndrome	9.5
1523	prostatic hyperplasia, benign	9.5
1524	epilepsy, childhood absence 1	9.5
1525	retinitis pigmentosa 11	9.5
1526	aminopterin syndrome sine aminopterin	9.5
1527	loose anagen hair syndrome	9.5
1528	budd-chiari syndrome	9.5
1529	brody disease	9.5
1530	cd4/cd8 t-cell ratio	9.5
1531	dental anomalies and short stature	9.5
1532	neurofibromatosis-noonan syndrome	9.5
1533	retinitis pigmentosa 18	9.5
1534	inflammatory bowel disease 2	9.5
1535	athabaskan brainstem dysgenesis syndrome	9.5
1536	neural tube defects, folate-sensitive	9.5
1537	suppressor of tumorigenicity 11	9.5
1538	hyperhomocysteinemia	9.5
1539	polydactyly	9.5
1540	urinary tract infections, recurrent	9.5
1541	brittle bone disorder	9.5
1542	ventricular fibrillation, paroxysmal familial, 1	9.5
1543	intervertebral disc disease	9.5
1544	microvascular complications of diabetes 1	9.5
1545	epidermolysis bullosa pruriginosa	9.5
1546	chudley-mccullough syndrome	9.5
1547	psoriasis 5	9.5
1548	becker nevus syndrome	9.5
1549	glycine encephalopathy	9.5
1550	phelan-mcdermid syndrome	9.5
1551	mental retardation, microcephaly, growth retardation, joint contractures, and facial dysmorphism	9.5
1552	huntington disease-like 2	9.5
1553	gastrointestinal stromal tumor	9.5
1554	glucose/galactose malabsorption	9.5
1555	meningioma, familial	9.5
1556	celiac disease 5	9.5
1557	hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration	9.5
1558	coronary heart disease 1	9.5
1559	patent ductus arteriosus 1	9.5
1560	niemann-pick disease, type c2	9.5
1561	hypertensive nephropathy	9.5
1562	aica-ribosuria due to atic deficiency	9.5
1563	ichthyosis with confetti	9.5
1564	loeys-dietz syndrome 1	9.5
1565	celiac disease 4	9.5
1566	hypothyroidism, congenital, nongoitrous, 3	9.5
1567	corneal dystrophy, congenital stromal	9.5
1568	alcohol sensitivity, acute	9.5
1569	psoriasis 8	9.5
1570	epilepsy, idiopathic generalized 13	9.5
1571	malaria	9.5
1572	celiac disease 10	9.5
1573	celiac disease 12	9.5
1574	ewing sarcoma	9.5
1575	immunodeficiency 68	9.5
1576	pseudofolliculitis barbae	9.5
1577	congenital disorder of glycosylation, type iq	9.5
1578	psoriasis 10	9.5
1579	factor xi deficiency	9.5
1580	immunodeficiency 10	9.5
1581	macs syndrome	9.5
1582	muscular dystrophy, congenital, lmna-related	9.5
1583	waardenburg syndrome, type 4b	9.5
1584	waardenburg syndrome, type 4c	9.5
1585	fatty liver disease 1	9.5
1586	muscle hypertrophy	9.5
1587	mannose-binding lectin deficiency	9.5
1588	pregnancy loss, recurrent 1	9.5
1589	familial cold autoinflammatory syndrome 3	9.5
1590	meconium ileus	9.5
1591	cataract 38	9.5
1592	short stature, optic nerve atrophy, and pelger-huet anomaly	9.5
1593	microcephaly, short stature, and polymicrogyria with or without seizures	9.5
1594	riboflavin deficiency	9.5
1595	facial dysmorphism, immunodeficiency, livedo, and short stature	9.5
1596	leukemia, acute lymphoblastic 3	9.5
1597	immunodeficiency 19	9.5
1598	cholangiocarcinoma	9.5
1599	cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis	9.5
1600	glucocorticoid resistance, generalized	9.5
1601	analbuminemia	9.5
1602	immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation	9.5
1603	thrombocytopenia 5	9.5
1604	hyperlipoproteinemia, type iii	9.5
1605	mulchandani-bhoj-conlin syndrome	9.5
1606	central centrifugal cicatricial alopecia	9.5
1607	aortic valve disease 3	9.5
1608	pancreatic cancer 5	9.5
1609	lipoprotein quantitative trait locus	9.5
1610	iron overload	9.5
1611	peyronie's disease	9.5
1612	chlorhexidine allergy	9.5
1613	autoimmune gastritis	9.5
1614	autoimmune pancreatitis	9.5
1615	superficial mycosis	9.5
1616	acute diarrhea	9.5
1617	aspiration pneumonia	9.5
1618	cryptogenic organizing pneumonia	9.5
1619	lambert-eaton myasthenic syndrome	9.5
1620	granulomatous amebic encephalitis	9.5
1621	fusariosis	9.5
1622	familial adenomatous polyposis	9.5
1623	restless legs syndrome	9.5
1624	usher syndrome	9.5
1625	lissencephaly	9.5
1626	periventricular nodular heterotopia	9.5
1627	loeys-dietz syndrome	9.5
1628	epidemic typhus	9.5
1629	variola major	9.5
1630	funisitis	9.5
1631	metabolic acidosis	9.5
1632	progressive relapsing multiple sclerosis	9.5
1633	third-degree atrioventricular block	9.5
1634	rheumatic heart disease	9.5
1635	peripheral artery disease	9.5
1636	limb ischemia	9.5
1637	oppositional defiant disorder	9.5
1638	colorectal adenocarcinoma	9.5
1639	fibroma	9.5
1640	ovarian serous carcinoma	9.5
1641	breast lobular carcinoma	9.5
1642	microscopic colitis	9.5
1643	jejunoileitis	9.5
1644	atrial fibrillation	9.5
1645	scoliosis	9.5
1646	gallbladder disease	9.5
1647	persistent generalized lymphadenopathy	9.5
1648	oral hairy leukoplakia	9.5
1649	inguinal hernia	9.5
1650	umbilical hernia	9.5
1651	breast abscess	9.5
1652	acrodermatitis chronica atrophicans	9.5
1653	chromosome 1p36 deletion syndrome	9.5
1654	purpura fulminans	9.5
1655	lethal congenital contracture syndrome	9.5
1656	spinal disease	9.5
1657	congenital central hypoventilation syndrome	9.5
1658	griscelli syndrome	9.5
1659	isolated growth hormone deficiency	9.5
1660	progressive familial intrahepatic cholestasis	9.5
1661	primary autosomal recessive microcephaly	9.5
1662	primary microcephaly	9.5
1663	miliaria pustulosa	9.5
1664	cerebellar hypoplasia	9.5
1665	physical disorder	9.5
1666	cryptococcal meningitis	9.5
1667	polycystic kidney disease	9.5
1668	x-linked chondrodysplasia punctata 2	9.5
1669	chronic eosinophilic leukemia	9.5
1670	non-alcoholic steatohepatitis	9.5
1671	tongue carcinoma	9.5
1672	polymicrogyria	9.5
1673	serum amyloid a amyloidosis	9.5
1674	nonobstructive coronary artery disease	9.5
1675	non-severe covid-19	9.5
1676	t-cell prolymphocytic leukemia	9.5
1677	acute myelomonocytic leukemia	9.5
1678	familial woolly hair syndrome	9.5
1679	familial adult myoclonic epilepsy	9.5
1680	sensorineural hearing loss	9.5
1681	endometritis	9.5
1682	intracranial abscess	9.5
1683	sleeping sickness	9.5
1684	ehrlichiosis	9.5
1685	otorrhea	9.5
1686	berylliosis	9.5
1687	blepharophimosis	9.5
1688	amblyopia	9.5
1689	meningoencephalitis	9.5
1690	blind loop syndrome	9.5
1691	microphthalmia	9.5
1692	thrombotic thrombocytopenic purpura	9.5
1693	mesenteric lymphadenitis	9.5
1694	methemoglobinemia	9.5
1695	hand, foot and mouth disease	9.5
1696	dissociative disorder	9.5
1697	impulse control disorder	9.5
1698	lipoid nephrosis	9.5
1699	spastic hemiplegia	9.5
1700	hemiplegia	9.5
1701	corneal edema	9.5
1702	leech infestation	9.5
1703	hydronephrosis	9.5
1704	hypoparathyroidism	9.5
1705	acute contagious conjunctivitis	9.5
1706	acute hemorrhagic conjunctivitis	9.5
1707	spondyloarthropathy	9.5
1708	orbital cellulitis	9.5
1709	microcytic anemia	9.5
1710	rabies	9.5
1711	lens subluxation	9.5
1712	pulmonary edema	9.5
1713	heart disease	9.5
1714	constrictive pericarditis	9.5
1715	cardiac tamponade	9.5
1716	mitral valve insufficiency	9.5
1717	suppurative otitis media	9.5
1718	fissured tongue	9.5
1719	hypertensive heart disease	9.5
1720	corneal deposit	9.5
1721	hyperandrogenism	9.5
1722	palindromic rheumatism	9.5
1723	portal vein thrombosis	9.5
1724	denture stomatitis	9.5
1725	tinea cruris	9.5
1726	panuveitis	9.5
1727	cryptococcosis	9.5
1728	hemosiderosis	9.5
1729	dysthymic disorder	9.5
1730	aseptic meningitis	9.5
1731	superficial keratitis	9.5
1732	vogt-koyanagi-harada disease	9.5
1733	dysentery	9.5
1734	entropion	9.5
1735	pathological gambling	9.5
1736	capillariasis	9.5
1737	hepatitis a	9.5
1738	paracoccidioidomycosis	9.5
1739	vestibular neuronitis	9.5
1740	leiomyoma	9.5
1741	enterocele	9.5
1742	choreatic disease	9.5
1743	keratoconjunctivitis sicca	9.5
1744	central retinal artery occlusion	9.5
1745	crescentic glomerulonephritis	9.5
1746	nontoxic goiter	9.5
1747	exocrine pancreatic insufficiency	9.5
1748	congenital toxoplasmosis	9.5
1749	tinea manuum	9.5
1750	scrub typhus	9.5
1751	pure red-cell aplasia	9.5
1752	scleritis	9.5
1753	alveolar periostitis	9.5
1754	sapho syndrome	9.5
1755	mature cataract	9.5
1756	fox-fordyce disease	9.5
1757	familial hypercholesterolemia	9.5
1758	white piedra	9.5
1759	small intestine lymphoma	9.5
1760	poems syndrome	9.5
1761	phaeohyphomycosis	9.5
1762	iritis	9.5
1763	acute poststreptococcal glomerulonephritis	9.5
1764	plasmodium falciparum malaria	9.5
1765	epicondylitis	9.5
1766	renal tubular acidosis	9.5
1767	ochronosis	9.5
1768	azoospermia	9.5
1769	chronic purulent otitis media	9.5
1770	primary hypertrophic osteoarthropathy	9.5
1771	noonan syndrome with multiple lentigines	9.5
1772	generalized anxiety disorder	9.5
1773	postencephalitic parkinson disease	9.5
1774	pyuria	9.5
1775	dracunculiasis	9.5
1776	sporotrichosis	9.5
1777	niemann-pick disease	9.5
1778	candidal paronychia	9.5
1779	reye syndrome	9.5
1780	hereditary angioedema	9.5
1781	lymphangioma	9.5
1782	gingival disease	9.5
1783	limited scleroderma	9.5
1784	diffuse scleroderma	9.5
1785	ventricular septal defect	9.5
1786	retinal vein occlusion	9.5
1787	cryptosporidiosis	9.5
1788	pancreatic endocrine carcinoma	9.5
1789	urinary system disease	9.5
1790	neuroendocrine carcinoma	9.5
1791	neuritis	9.5
1792	intrahepatic cholestasis	9.5
1793	atrial heart septal defect	9.5
1794	optic nerve disease	9.5
1795	noninfectious dermatoses of eyelid	9.5
1796	malignant fibrous histiocytoma	9.5
1797	hyperuricemia	9.5
1798	hypogonadism	9.5
1799	fallopian tube carcinoma	9.5
1800	leiomyosarcoma	9.5
1801	hyperostosis	9.5
1802	chronic mucocutaneous candidiasis	9.5
1803	cystoisosporiasis	9.5
1804	coccidiosis	9.5
1805	granulomatous hepatitis	9.5
1806	ankylosis	9.5
1807	capillary lymphangioma	9.5
1808	leptospirosis	9.5
1809	nocardiosis	9.5
1810	colon adenocarcinoma	9.5
1811	craniosynostosis	9.5
1812	macrocytic anemia	9.5
1813	glomus tumor	9.5
1814	central retinal vein occlusion	9.5
1815	protein s deficiency	9.5
1816	psychotic disorder	9.5
1817	orchitis	9.5
1818	kidney cancer	9.5
1819	pigmented villonodular synovitis	9.5
1820	phimosis	9.5
1821	bilirubin metabolic disorder	9.5
1822	glycogen storage disease	9.5
1823	bronchiolitis obliterans	9.5
1824	acquired polycythemia	9.5
1825	euthyroid sick syndrome	9.5
1826	membranoproliferative glomerulonephritis	9.5
1827	periarthritis	9.5
1828	kidney papillary necrosis	9.5
1829	anuria	9.5
1830	mucinous adenocarcinoma	9.5
1831	ascaridiasis	9.5
1832	serous cystadenocarcinoma	9.5
1833	gallbladder cancer	9.5
1834	anus disease	9.5
1835	scalp dermatosis	9.5
1836	tenosynovial giant cell tumor	9.5
1837	scleredema adultorum	9.5
1838	mucinoses	9.5
1839	lipomatosis	9.5
1840	hand dermatosis	9.5
1841	skin benign neoplasm	9.5
1842	skin papilloma	9.5
1843	complex regional pain syndrome	9.5
1844	syringomyelia	9.5
1845	mixed germ cell cancer	9.5
1846	teratoma	9.5
1847	angiomyolipoma	9.5
1848	laryngitis	9.5
1849	systemic mastocytosis	9.5
1850	superior mesenteric artery syndrome	9.5
1851	appendix adenocarcinoma	9.5
1852	kallmann syndrome	9.5
1853	mast cell neoplasm	9.5
1854	cervical adenocarcinoma	9.5
1855	ovary adenocarcinoma	9.5
1856	gastric adenocarcinoma	9.5
1857	verrucous carcinoma	9.5
1858	vaginal discharge	9.5
1859	acute myocarditis	9.5
1860	lymphocytic gastritis	9.5
1861	tick infestation	9.5
1862	nail disease	9.5
1863	biliary dyskinesia	9.5
1864	carcinosarcoma	9.5
1865	coronary stenosis	9.5
1866	ebola hemorrhagic fever	9.5
1867	erdheim-chester disease	9.5
1868	non-langerhans-cell histiocytosis	9.5
1869	amelanotic melanoma	9.5
1870	neuromuscular disease	9.5
1871	fibrous histiocytoma	9.5
1872	somatostatinoma	9.5
1873	pancreatic somatostatinoma	9.5
1874	dysgerminoma	9.5
1875	breast angiosarcoma	9.5
1876	conventional angiosarcoma	9.5
1877	bile duct cancer	9.5
1878	uremia	9.5
1879	endophthalmitis	9.5
1880	calciphylaxis	9.5
1881	sebaceous adenocarcinoma	9.5
1882	small intestine adenocarcinoma	9.5
1883	myelodysplastic/myeloproliferative neoplasm	9.5
1884	essential tremor	9.5
1885	basosquamous carcinoma	9.5
1886	adjustment disorder	9.5
1887	thoracic cancer	9.5
1888	aortitis	9.5
1889	gingival hypertrophy	9.5
1890	dystonia	9.5
1891	eccrine acrospiroma	9.5
1892	spiradenoma	9.5
1893	mediastinal cancer	9.5
1894	retinal disease	9.5
1895	adenosine deaminase deficiency	9.5
1896	hemoglobinuria	9.5
1897	gray zone lymphoma	9.5
1898	silent myocardial infarction	9.5
1899	panic disorder	9.5
1900	congestive heart failure	9.5
1901	blood protein disease	9.5
1902	chronic lymphocytic leukemia/small lymphocytic lymphoma	9.5
1903	acral lentiginous melanoma	9.5
1904	progressive multifocal leukoencephalopathy	9.5
1905	bilateral breast cancer	9.5
1906	mediastinal gray zone lymphoma	9.5
1907	skin tag	9.5
1908	anal canal squamous cell carcinoma	9.5
1909	malignant pleural mesothelioma	9.5
1910	lymphatic system disease	9.5
1911	childhood leukemia	9.5
1912	delusional disorder	9.5
1913	end stage renal disease	9.5
1914	tertiary syphilis	9.5
1915	trombiculiasis	9.5
1916	kidney angiomyolipoma	9.5
1917	intestinal obstruction	9.5
1918	ileus	9.5
1919	retinal artery occlusion	9.5
1920	rheumatoid arthritis interstitial lung disease	9.5
1921	fundus dystrophy	9.5
1922	chronic monocytic leukemia	9.5
1923	neurofibromatosis	9.5
1924	vascular dementia	9.5
1925	milker's nodule	9.5
1926	metagonimiasis	9.5
1927	neuromyelitis optica	9.5
1928	evans' syndrome	9.5
1929	cowpox	9.5
1930	narcolepsy	9.5
1931	cervix uteri carcinoma in situ	9.5
1932	degenerative disc disease	9.5
1933	gastrointestinal lymphoma	9.5
1934	macroglobulinemia	9.5
1935	gas gangrene	9.5
1936	speech disorder	9.5
1937	periodic limb movement disorder	9.5
1938	herpes zoster oticus	9.5
1939	erythromelalgia	9.5
1940	waardenburg's syndrome	9.5
1941	priapism	9.5
1942	scotoma	9.5
1943	croup	9.5
1944	hypopituitarism	9.5
1945	acute myocardial infarction	9.5
1946	plantar fasciitis	9.5
1947	neurofibroma	9.5
1948	pathologic nystagmus	9.5
1949	aphthous stomatitis	9.5
1950	senile cataract	9.5
1951	ulcerative stomatitis	9.5
1952	pulmonary emphysema	9.5
1953	purulent endophthalmitis	9.5
1954	diabetic neuropathy	9.5
1955	congenital syphilis	9.5
1956	muscular dystrophy	9.5
1957	hordeolum	9.5
1958	periostitis	9.5
1959	drug dependence	9.5
1960	bap1 tumor predisposition syndrome	9.5
1961	creatine deficiency disorders	9.5
1962	dysferlinopathy	9.5
1963	etv6 thrombocytopenia and predisposition to leukemia	9.5
1964	trichorhinophalangeal syndrome	9.5
1965	type ii collagen disorders	9.5
1966	was-related disorders	9.5
1967	acquired hemophilia	9.5
1968	allergic encephalomyelitis	9.5
1969	arrhinia	9.5
1970	autoimmune polyglandular syndrome type 3	9.5
1971	autoimmune retinopathy	9.5
1972	beryllium disease	9.5
1973	bronchopulmonary dysplasia	9.5
1974	c1q nephropathy	9.5
1975	candida glabrata	9.5
1976	cataract-glaucoma	9.5
1977	chronic lymphocytic inflammation with pontine perivascular enhancement responsiv	9.5
1978	clostridium septicum infection	9.5
1979	cold urticaria	9.5
1980	coloboma of iris	9.5
1981	congenital contractures	9.5
1982	congenital human immunodeficiency virus	9.5
1983	creeping myiasis	9.5
1984	engraftment syndrome	9.5
1985	eosinophilic pustular folliculitis	9.5
1986	exercise-induced anaphylaxis	9.5
1987	exogenous ochronosis	9.5
1988	fibromatosis	9.5
1989	functioning pancreatic endocrine tumor	9.5
1990	gardner-diamond syndrome	9.5
1991	glioma	9.5
1992	heavy metal poisoning	9.5
1993	hemophilia	9.5
1994	herpes zoster ophthalmicus	9.5
1995	hydroa vacciniforme	9.5
1996	hypoaldosteronism	9.5
1997	ichthyosis follicularis atrichia photophobia syndrome	9.5
1998	ichthyosis, follicular	9.5
1999	interferon gamma, receptor 1, deficiency	9.5
2000	kikuchi disease	9.5
2001	laugier-hunziker syndrome	9.5
2002	ledderhose disease	9.5
2003	leukoplakia	9.5
2004	lichen planus pemphigoides	9.5
2005	lipodermatosclerosis	9.5
2006	lymphomatoid granulomatosis	9.5
2007	marek disease	9.5
2008	mast cell activation syndrome	9.5
2009	meningococcal infection	9.5
2010	microscopic polyangiitis	9.5
2011	morgellons	9.5
2012	mycetoma	9.5
2013	mycobacterium abscessus	9.5
2014	notalgia paresthetica	9.5
2015	paraneoplastic neurologic disorders	9.5
2016	perniosis	9.5
2017	primary localized cutaneous nodular amyloidosis	9.5
2018	quinquaud folliculitis decalvans	9.5
2019	rheumatoid vasculitis	9.5
2020	ring chromosome 2	9.5
2021	secondary adrenal insufficiency	9.5
2022	spitz nevus	9.5
2023	sunct headache	9.5
2024	treponema infection	9.5
2025	undifferentiated connective tissue disease	9.5
2026	weber syndrome	9.5
2027	back pain	9.5
2028	chronic pain	9.5
2029	febrile seizures	9.5
2030	foot drop	9.5
2031	hypotonia	9.5
2032	spinal cord injury	9.5
2033	tremor	9.5
2034	chronic cutaneous lupus erythematosus	9.5
2035	localized pagetoid reticulosis	9.5
2036	interatrial communication	9.5
2037	rare systemic disease	9.5
2038	glial tumor	9.5
2039	chronic beryllium disease	9.5
2040	acute transverse myelitis	9.5
2041	hemimelia	9.5
2042	ichthyosis follicularis-alopecia-photophobia syndrome	9.5
2043	overlapping connective tissue disease	9.5
2044	qualitative or quantitative defects of dysferlin	9.5
2045	rare lymphatic malformation	9.5
2046	autoimmune polyendocrinopathy type 3	9.5
2047	toxic oil syndrome	9.5
2048	acute sensory ataxic neuropathy	9.5
2049	idiopathic nephrotic syndrome	9.5
2050	toxic dermatosis	9.5
2051	hypocalcemic rickets	9.5
2052	familial intrahepatic cholestasis	9.5
2053	disorder of galactose metabolism	9.5
2054	acute radiation syndrome	9.5
2055	cutaneous pseudolymphoma	9.5
2056	chronic enteropathy associated with slco2a1 gene	9.5
2057	eosinophilic colitis	9.5
2058	polyarticular juvenile idiopathic arthritis	9.5
2059	refractory celiac disease	9.5
2060	3q27.3 microdeletion syndrome	9.5
2061	urachal sinus	9.5
2062	neuroendocrine carcinoma of pancreas	9.5
2063	acute monoblastic/monocytic leukemia	9.5
2064	familial keratoacanthoma	9.5
2065	non-histaminic angioedema	9.5
2066	benign idiopathic neonatal seizures	9.5
2067	pneumococcal meningitis	9.5
2068	methotrexate toxicity	9.5
2069	inherited retinal disorder	9.5
2070	classic pyoderma gangrenosum	9.5
2071	striate palmoplantar keratoderma	9.5
2072	autoimmune hemolytic anemia, warm type	9.5
2073	lupus erythematosus panniculitis	9.5
2074	fungal keratitis	9.5
2075	pauci-immune glomerulonephritis	9.5
2076	pemphigus vegetans	9.5
2077	classic phenylketonuria	9.5
2078	erythrokeratoderma	9.5
2079	refractory anemia with excess blasts	9.5
2080	rare tumor	9.5
2081	acute adrenal insufficiency	9.5
2082	refractory anemia	9.5
2083	multiple congenital anomalies/dysmorphic syndrome-intellectual disability	9.5
2084	thyroid carcinoma	9.5
2085	cutaneous myiasis	9.5
2086	idiopathic syringomyelia	9.5

Graphical network of the top 20 diseases related to Dermatitis:

Sources

Symptoms & Phenotypes for Dermatitis

UMLS symptoms related to Dermatitis:

pruritus; exanthema

MGI Mouse Phenotypes related to Dermatitis:

⁴⁵ (showing 2, show less)

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	immune system	MP:0005387	9.77	CCL11 CCL17 CCL22 CMA1 IGHE IL13
2	hematopoietic system	MP:0005397	9.44	CCL11 CCL17 CMA1 DSG1 IGHE IL13

Sources

Drugs & Therapeutics for Dermatitis

PubMed Health treatment related to Dermatitis: ⁶³

Eczema is a chronic condition. Treatment cannot cure it, but regular skin care and medication can help to keep the itching and rash at bay. The main treatment options are: Basic treatment : Lipid -replenishing and moisturizing products (emollients ) are generously applied to the skin at least twice a day to keep it from drying out. This can help relieve itching and protect the skin from germs and irritants. Special soaps, liquid cleansers and shampoos : Normal soaps and products like shampoo or shower gel contain various substances that can dry out your skin . Special cleansing products without these substances are available to get around this problem. But basic treatment with emollients can usually compensate for the loss of moisture caused by normal soaps. Steroid creams : Eczema flare -ups are usually treated with steroid creams because they can relieve the itching and inflammation . They are typically used only for acute symptoms. But they are sometimes used at regular intervals together with moisturizing skin care products (basic treatment ): for example, as a "weekend treatment" where a steroid cream is applied on one or two days a week. Pimecrolimus and tacrolimus : Pimecrolimus and tacrolimus are two other medicines that can be used to treat eczema . They are not approved for use in children under the age of two years, though. These two medicines are also applied to the skin in a cream or ointment, and can be used if steroid products are not an option. This might be the case if steroid treatment is not tolerated or is ineffective. Pimecrolimus and tacrolimus may also be an option for long-term treatment of sensitive skin in the face and neck area. They can also be used on one or two days per week only, as described above. Other eczema treatment options include wet wraps, UV radiation and medications that suppress certain immune responses. Tablets containing these medicines are used if other treatments don't work, or if the eczema is very severe or affects large areas of skin . Because they have an effect throughout the entire body, they may have more extensive side effects than topical treatments. Allergy medications (antihistamines ) are also commonly used to relieve itching . But research has now shown that they are not suitable for treating eczema , whether used as tablets or a cream. People often try out herbal products or dietary supplements, such as evening primrose oil , borage oil, vitamin B6, vitamin E and zinc . But research hasn't shown that these products are effective. Many other treatments such as laser therapies or hyposensitization have not yet been studied enough, so they are not recommended by medical associations.

Drugs for Dermatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 471, show less)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Salicylic acid

Approved, Investigational, Vet_approved

Phase 4

69-72-7

338

Ciclopirox

Approved, Investigational

Phase 4

29342-05-0

2749

Titanium dioxide

Approved

Phase 4

13463-67-7

Glycerin

Approved, Investigational

Phase 4

56-81-5

753

Carbamide peroxide

Approved

Phase 4

124-43-6

Clobetasol

Approved, Experimental, Investigational

Phase 4

25122-46-7, 25122-41-2

2791 5311051 32798

Omalizumab

Approved, Investigational

Phase 4

242138-07-4

Levocetirizine

Approved

Phase 4

130018-77-8

1549000

Triclosan

Approved, Investigational

Phase 4

3380-34-5

5564

Desonide

Approved, Investigational

Phase 4

638-94-8

5311066

Montelukast

Approved

Phase 4

158966-92-8

5281040

Methylprednisolone aceponate

Approved, Vet_approved

Phase 4

86401-95-8

4474933

Lidocaine

Approved, Vet_approved

Phase 4

137-58-6

3676

Racepinephrine

Approved, Vet_approved

Phase 4

51-43-4, 329-65-7

838 5816

Fluocinonide

Approved, Investigational

Phase 4

356-12-7

9642

Desoximetasone

Approved

Phase 4

382-67-2

5311067

Menthol

Approved, Experimental

Phase 4

1490-04-6, 2216-51-5, 15356-60-2

1254 16666 165675

Brodalumab

Approved, Investigational

Phase 4

1174395-19-7

Mometasone furoate

Approved, Investigational, Vet_approved

Phase 4

83919-23-7

4240 441336

Dicloxacillin

Approved, Investigational, Vet_approved

Phase 4

3116-76-5

18381

Methotrexate

Approved

Phase 4

1959-05-2, 59-05-2

4112 126941

Mycophenolic acid

Approved, Investigational

Phase 4

24280-93-1

446541

Apremilast

Approved, Investigational

Phase 4

608141-41-9

10151715 11561674

Betamethasone

Approved, Vet_approved

Phase 4

378-44-9

9782

Alitretinoin

Approved, Investigational

Phase 4

5300-03-8

449171

Pimecrolimus

Approved, Investigational

Phase 4

137071-32-0

17753757 6509979

Zinc cation

Approved, Experimental, Investigational

Phase 4

7440-66-6, 23713-49-7

32051

Zinc oxide

Approved

Phase 4

1314-13-2

Triamcinolone

Approved, Vet_approved

Phase 4

124-94-7

31307

Benzocaine

Approved, Investigational

Phase 4

1994-09-7, 94-09-7

2337

Tannic acid

Approved

Phase 4

1401-55-4

16129878 16129778

Levoleucovorin

Approved, Experimental, Investigational

Phase 4

68538-85-2, 58-05-9, 73951-54-9

149436 6006

Lactitol

Approved, Investigational

Phase 4

585-86-4

157355

Alefacept

Approved, Investigational, Withdrawn

Phase 4

222535-22-0

Dapsone

Approved, Investigational

Phase 4

80-08-0

2955

Cefuroxime

Approved

Phase 4

55268-75-2

5479529

Folic acid

Approved, Nutraceutical, Vet_approved

Phase 4

59-30-3

6037

Halometasone

Experimental

Phase 4

50629-82-8

12811517

Cortisone

Experimental

Phase 4

53-06-5

222786

Cyclooxygenase Inhibitors

Phase 4

Salicylates

Phase 4

Acidophilus

Phase 4

Immunoglobulin E

Phase 4

Histamine H1 Antagonists, Non-Sedating

Phase 4

Olive

Phase 4

Leukotriene Antagonists

Phase 4

Anti-Arrhythmia Agents

Phase 4

Sodium Channel Blockers

Phase 4

Diuretics, Potassium Sparing

Phase 4

Epinephryl borate

Phase 4

Evening Primrose

Phase 4

Linoleate

Phase 4

Pharmaceutical Solutions

Phase 4

Immunoglobulin A

Phase 4

Antitubercular Agents

Phase 4

Anti-Asthmatic Agents

Phase 4

Respiratory System Agents

Phase 4

Analgesics

Phase 4

Phosphodiesterase Inhibitors

Phase 4

Phosphodiesterase 4 Inhibitors

Phase 4

Anti-Inflammatory Agents, Non-Steroidal

Phase 4

Analgesics, Non-Narcotic

Phase 4

Hormones

Phase 4

Betamethasone-17,21-dipropionate

Phase 4

Betamethasone Valerate

Phase 4

2152-44-5

Betamethasone sodium phosphate

Phase 4

Betamethasone benzoate

Phase 4

Hormone Antagonists

Phase 4

glucocorticoids

Phase 4

Immunoglobulins

Phase 4

Antibodies

Phase 4

Anti-Infective Agents, Local

Phase 4

Gentamicins

Phase 4

Cytochrome P-450 Enzyme Inhibitors

Phase 4

Cytochrome P-450 CYP3A Inhibitors

Phase 4

Antibodies, Monoclonal

Phase 4

Triamcinolone hexacetonide

Phase 4

Triamcinolone diacetate

Phase 4

Triamcinolone Acetonide

Phase 4

6436

Vitamin B Complex

Phase 4

Folic Acid Antagonists

Phase 4

Folate

Phase 4

Vitamin B9

Phase 4

Antiprotozoal Agents

Phase 4

Antiparasitic Agents

Phase 4

Antimalarials

Phase 4

Radiation-Protective Agents

Phase 4

Cathartics

Phase 4

Laxatives

Phase 4

Cefuroxime axetil

Phase 4

3379942

Penicillins

Phase 4

Histidine

Investigational, Nutraceutical

Phase 4

71-00-1

6274

Cimetidine

Approved, Investigational

Phase 3

51481-61-9

2756

Fexofenadine

Approved, Investigational

Phase 2, Phase 3

83799-24-0

3348

Cetirizine

Approved

Phase 3

83881-51-0

2678

Desloratadine

Approved, Investigational

Phase 3

100643-71-8

124087

Polymyxin B

Approved, Vet_approved

Phase 3

1405-20-5, 1404-26-8

4868

Tolnaftate

Approved, Investigational, Vet_approved

Phase 3

2398-96-1

5510

Lactulose

Approved

Phase 2, Phase 3

4618-18-2

11333

100

Hyaluronic acid

Approved, Vet_approved

Phase 3

9004-61-9

53477741

101

Ketotifen

Approved

Phase 3

34580-14-8, 34580-13-7

3827

102

Bepotastine

Approved

Phase 3

190786-44-8, 125602-71-3

2350 164522

103

Butenafine

Approved

Phase 3

101828-21-1

2484

104

Epinastine

Approved, Investigational

Phase 3

80012-43-7

3241

105

Curcumin

Approved, Investigational

Phase 2, Phase 3

458-37-7, 84765-67-3

969516

106

Cetuximab

Approved

Phase 3

205923-56-4

107

Acitretin

Approved

Phase 2, Phase 3

55079-83-9

5284513

108

Infliximab

Approved

Phase 3

170277-31-3

109

Tocopherol

Approved, Investigational

Phase 3

1406-66-2

110

Afamelanotide

Approved, Investigational

Phase 3

75921-69-6

16132954 16197727

111

Abrocitinib

Approved, Investigational

Phase 3

1622902-68-4

78323835

112

Cannabidiol

Approved, Investigational

Phase 3

13956-29-1

521372 644019

113

Ustekinumab

Approved, Investigational

Phase 2, Phase 3

815610-63-0

114

Adalimumab

Approved, Experimental

Phase 2, Phase 3

331731-18-1

115

Ketoconazole

Approved, Investigational

Phase 3

65277-42-1, 142128-57-2

47576 3823 638701

116

BCG vaccine

Approved, Investigational

Phase 3

117

Fluocinolone acetonide

Approved, Investigational, Vet_approved

Phase 3

67-73-2

6215

118

Fluticasone

Approved, Experimental

Phase 3

90566-53-3

4659387 5311101

119

Fusidic acid

Approved, Investigational

Phase 3

6990-06-3

3000226

120

Coconut

Approved

Phase 3

121

Crofelemer

Approved

Phase 3

33507-63-0, 148465-45-6

36511 44359816

122

Vitamin A

Approved, Nutraceutical, Vet_approved

Phase 3

22737-96-8, 68-26-8

5280382 445354

123

Melatonin

Approved, Nutraceutical, Vet_approved

Phase 2, Phase 3

73-31-4

896

124

DL-alpha-Tocopherol

Approved, Experimental, Investigational, Nutraceutical, Vet_approved

Phase 3

59-02-9, 10191-41-0

2116 14985

125

Cholecalciferol

Approved, Nutraceutical, Vet_approved

Phase 3

67-97-0, 1406-16-2

5280795 10883523

126

Maleic acid

Experimental, Investigational

Phase 3

110-16-7, 110-17-8

444266 444972

Dermatitis

Aliases & Classifications for Dermatitis

MalaCards integrated aliases for Dermatitis:

Classifications:

External Ids:

Summaries for Dermatitis

Related Diseases for Dermatitis

Diseases related to Dermatitis via text searches within MalaCards or GeneCards Suite gene sharing:

Graphical network of the top 20 diseases related to Dermatitis:

Symptoms & Phenotypes for Dermatitis

UMLS symptoms related to Dermatitis:

MGI Mouse Phenotypes related to Dermatitis:

Drugs & Therapeutics for Dermatitis

PubMed Health treatment related to Dermatitis: 63

Drugs for Dermatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

PubMed Health treatment related to Dermatitis: ⁶³